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1 Zusammenfassung 
Die Biogenese von Ribosomen ist ein komplexer Vorgang, dessen erster Schritt die 
Transkription der ribosomalen RNS (rRNS) Gene beinhaltet. Das menschliche, sowie das 
Maus Genom enthalten je ungefähr 400 Kopien dieser rRNS Gene. Die Gene liegen in 
Einheiten vor, die sich auf verschiedenen Chromosomen wiederholen. Die Transkription 
der rRNS Gene unterliegt epigenetischen Regulationsmechanismen. Hierbei spielt unter 
anderem DNS Methylierung eine wichtige Rolle. Jüngste Studien konnten zeigen, dass 
die epigenetische Hemmung der rRNS Gene durch den Entwicklungs- bzw. den 
Differenzierungsstatus einer Zelle reguliert wird. In embryonalen Stammzellen (ESCs) 
werden alle rRNS Gene aktiv transkribiert und erst während der Differenzierung wird die 
Promotorsequenz einiger Gene methyliert und diese somit in ihrer Transkription gehemmt. 
Dass es Stammzellen nicht möglich ist zu differenzieren wenn die Bildung von 
Heterochromatin in bestimmten Bereichen der rRNS Gene inhibiert wird, unterstreicht die 
Wichtigkeit dieses Prozesses.  
Die Regulationsmechanismen, welche die Transkription von rRNS Gene während der 
Differenzierung orchestrieren sind größten Teils bekannt. Allerdings bleibt noch zu klären, 
ob die epigenetische Hemmung der rRNS Gene ein zufälliger Prozess ist (jedes rRNS 
Gen kann zufällig methyliert werden) oder ob bestimmte Subklassen von rRNS Genen 
spezifisch methyliert und so in ihrer Transkription gehemmt werden.  
Frühere Studien haben gezeigt, dass rRNS Gene nicht alle die gleiche Sequenz 
aufweisen. Unterschiede zwischen den Sequenzen finden sich sowohl zwischen 
unterschiedlichen Individuen, als auch innerhalb der rRNS Sequenzen des gleichen 
Individuums. In der Regel unterscheiden sich die rRNS Gene besonders in ihrer 
“intergenic spacer region” (Sequenz zwischen den jeweiligen rRNS Genen). Oft 
unterscheidet sich die Längen der jeweiligen „Enhancer“ Regionen, es sind aber auch 
Polymorphismen einzelner Nukleotide (Single nucleotide Polymorphism SNP) bekannt. 
Resultate verschiedener Studien, einschließlich Ergebnisse unserer Gruppe, haben SNPs 
an Position -104 und +44 relativ zum Transkriptionsstartpunkt identifiziert. Folglich können 
die rRNS Genvarianten entsprechend dieser Resultate anhand des vorliegenden SNP 
unterschieden werden (-104C, -104A, +44A, +44G und +44T). 
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Das Ziel dieser Arbeit war es, ein System zu etablieren, welches das Quantifizieren der 
rRNS Genvarianten verschiedener Individuen erlaubt, sowie die Analyse deren 
epigenetische Merkmale ermöglicht. Im Rahmen dieses Projektes haben wir eine 
quantitative Polymerasen Kettenreaktion (PCR) zur Quantifizierung der SNPs entwickelt, 
welche zuverlässig zwischen den jeweiligen rRNS Sequenzen unterscheidet und diese in 
verschiedenen Zelllinien und Geweben quantitativ messen kann. Des Weiteren haben wir 
diese Methode so angepasst, dass wir epigenetische Modifikationen im Verlauf der 
Differenzierung von Stammzellen analysieren können.  
Unsere Resultate zeigen eine unterschiedliche Verteilung der rRNS Genvarianten 
zwischen Individuen. Außerdem konnte gezeigt werden, dass die epigenetische 
Hemmung von rRNS Genvarianten kein zufälliger Prozess ist, sondern das gewisse rRNS 
Subklassen eher dazu neigen methyliert zu werden als andere. Diese Resultate legen 
nahe, dass bestimmte genetische Unterschiede der rRNS Sequenzen einen Einfluss auf 
ihren epigenetischen Status sowie ihre Transkriptionsaktivität haben. Die Entwicklung 
dieses spezifischen Systems wird in Zukunft sehr hilfreich sein um das Zusammenspiel 
von genetischen und epigenetischen Regulationsmechanismen auf die Aktivität von rRNS 
Genen besser zu verstehen. 
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2 Summary 
Transcription of ribosomal RNA (rRNA) genes is the initial event of ribosome biogenesis, 
a complex pathway dedicated to the production of ribosomes. Human and mice genomes 
contain about 400 copies of rRNA genes, which are organized into tandemly repeated 
clusters distributed among different chromosomes. rRNA gene transcription is regulated 
by epigenetic-mediated mechanisms, including CpG methylation. Recent results revealed 
that the establishment of epigenetic silencing at rRNA genes is developmental regulated. 
In embryonic stem cells (ESCs) all rRNA genes are transcriptionally active and only upon 
differentiation a fraction of genes undergoes epigenetic silencing through methylation of 
the promoter sequence. Formation of heterochromatin at a fraction of rRNA genes is 
critical since abrogation of this process impairs ESC differentiation. Although the 
mechanisms by which this process is regulated during ESC differentiation are in large part 
understood, it still remains to clarify whether epigenetic silencing at rRNA genes is a 
random event (i.e. any rRNA gene can be epigenetically silenced) or whether a defined 
set of rRNA genes is specifically CpG methylated and transcriptionally repressed.  
Early studies have shown that rRNA genes do not share the exact same sequence. 
Sequence heterogeneity can be observed between individuals but also between rRNA 
sequences in the same individual. This variation often occurs within the intergenic spacer 
regions and can be observed as different length of enhancer regions but also as single 
nucleotide polymorphism (SNP). Results from our and other laboratories have identified 
SNPs at position -104 and +44 relative to the transcription start site. These results 
indicate the presence of rRNA gene variants, which can be distinguished according to 
their SNP (-104C, -104A, +44A, +44G and +44T).  
The aim of this work was to establish a method that allows the quantification of rRNA 
gene variants among individuals and determine their epigenetic and transcription state. 
We developed a SNP quantitative PCR, which efficiently distinguishes rRNA sequence 
variation and allows quantitative measurement of the amounts of rRNA gene variants 
present in several cell lines and tissue. Moreover, we adapted this method to analyze the 
epigenetic state of rRNA gene variants during embryonic stem cell differentiation. The 
results revealed different abundance of rRNA gene variants among individuals and 
determined that upon ESC differentiation rRNA gene silencing is not a random event, but 
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that certain rRNA gene variants are more prone to acquire CpG methylation. The results 
suggest that the genetic variation among rRNA sequences influences their epigenetic and 
transcription state. The development of this SNP specific quantitative PCR represents an 
important tool for future studies aimed to dissect the crosstalk between genetic and 
epigenetic regulation at rRNA genes, which might be useful for the understanding of 
complex diseases like cancer.    
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3 Introduction  
3.1 Embryonic stem cells 
Embryonic stem cells are defined by their unlimited self-renew potential and their capacity 
to differentiate into any of the three germ layers, that constitute the vertebrate embryo (i.e. 
endoderm, mesoderm and ectoderm). Hence pluripotency can give rise to all the somatic 
lineages of the embryo as well as to the germline (Young 2011). The development of a 
totipotent zygote towards a blastocyst leads to this pluripotent state in vivo. Two lineages 
emerge during this developmental process: the inner cell mass (ICM), which gives rise to 
the pluripotent cell population, and the trophectoderm (TE), which forms the 
extraembryonic epithelial layer that encloses and supports the ICM (Fisher and Fisher 
2011). Embryonic stem cells (ESCs) can divide unlimitedly in vitro. Stem cells divide 
either asymmetrically or symmetrically. This process gives rise to one or two daughter 
stem cells with a comparable developmental potential to the mother cell. During 
symmetric division two identical sister cells are obtained, whereas asymmetric division 
gives rise to one cell, which retains the original phenotype of the mother cell, while the 
second cell acquire a new phenotype. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 The pluripotency of embryonic stem cells. Schema depicts the derivation of embryonic stem cells from inner cell mass (ICM) 
and their potential to generate all cell types. Picture was taken from https://www.sciencelearn.org.nz/resources/1965-stem-cells. 
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The self-renewal capacity is essential for stem cells to expand their number during 
development, to maintain stem cell pool within adult tissues and to restore the stem cell 
pool after injury (reviewed in (He, Nakada et al. 2009)). The potency of a stem cell reflects 
the variety of cell types that can potentially result through differentiation. The potency 
ranges from the totipotency of the zygote to the unipotency of some adult stem cells such 
as epithelial stem cells, which enable cell turnover in epithelia (Slack 2000). 
Because of these unique properties, ESCs are not only an ideal in vitro tool for studying 
early mammalian development, but they also offer a great therapeutic potential regarding 
regenerative medicine since they might be a potential source for cell and tissue 
replacement. In order to realize these potential clinical applications, the molecular and 
cellular mechanisms controlling pluripotency and differentiation need to be better 
understood. 
ESCs are derived from the ICM of E3.5-E4.5 mouse embryos using a variety of culture 
conditions, such as leukemia inhibitory factor (LIF) and fetal calf serum (FCS). Mouse 
ESCs appear as homogenous colonies of small tightly packed cells when cultured on a 
feeder layer of mitotically inactivated embryonic fibroblasts as well as in the presence of 
fetal calf serum (FCS) (Martin 1981, Nichols, Evans et al. 1990). The efficiency of those 
first steps in culturing ESCs was quite low and only further adjustments of the culture 
conditions allowed establishing of more stable and homogenous cell lines. In 1988, two 
different studies by Wiliams and Smith found that the self-renewal support coming from 
feeder cells arose from a cytokine called leukemia inhibitory factor (LIF) produced by 
these cells. LIF is a member of the IL6 family that binds to the leukemia inhibitory factor 
receptor (LIFR) and it can be isolated from the cytokine factors produced by the feeder 
cells ((Smith, Heath et al. 1988),(Williams, Hilton et al. 1988)). LIF promotes ESC self-
renewal by activating the transcription factor STAT3. The analysis of ESCs cultured under 
these conditions (LIF and serum) gave important insights into embryonic development 
and pluripotency.  
Recent developments have enabled the derivation of ESCs in defined serum-free medium 
supplemented with two small-molecule kinase inhibitors (2i): PD0325901 impairs the MAP 
kinase pathway and therefore blocks differentiation whereas CHIR99021 activates Wnt 
signaling and thus enhances self-renewal (Ying, Wray et al. 2008). These ESCs are 
suggested to represent the ground state of pluripotency.  
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As compared to conventional ESCs cultured in FCS, 2i ESCs are much more 
homogeneous in morphology and show higher clonogenicity (≥50%) (Gertsenstein, Nutter 
et al. 2010). There is growing evidence that not only the signalling but also the epigenetic 
make-up differs, suggesting that 2i and serum ESCs represent two different states of 
pluripotency. Therefore, it has been considered that 2i ESCs reflect earlier embryonic 
stages as serum ESCs (Marks and Stunnenberg 2014). 
 
3.1.1 Transcriptional network of pluripotency 
A complex network of transcription factors that activates self-renewal related genes and 
represses differentiation pathways is responsible for the maintenance of pluripotency in 
stem cells. In the past decades, several master regulators of this network have been 
identified, which include Oct4, SOX2 and Nanog that are considered to be crucial for the 
maintenance of the undifferentiated state.  
During mouse embryonic development, Oct4 is expressed within the totipotent 
blastomeres, pluripotent epiblast as well as in primordial germ cells (PGCs) ((Rosner, 
Vigano et al. 1990), (Scholer, Dressler et al. 1990)). SOX2 is expressed within the ICM 
and the extraembryonic ectoderm of pre-implantation embryos (Avilion, Nicolis et al. 
2003). Since Oct4 or SOX2 KO embryos are not able to form a pluripotent ICM and 
differentiate into trophectoderm it is suggested that both factors are essential to establish 
and maintain pluripotency (Avilion, Nicolis et al. 2003). In the absence of the leukemia 
inhibitor factor (LIF), Nanog is capable to sustain mESC self-renewal. Although Nanog KO 
embryos do not posses a pluripotent ICM, Nanog KO ESCs can be generated afterwards. 
Those ESCs are still pluripotent yet they tend to differentiate. Although they cannot give 
rise to PGCs they are still capable to contribute to chimeras, suggesting that Nanog is 
indispensable to establish the pluripotency of the ICM and to safeguard the pluripotent 
status of the germ line ((Chambers, Silva et al. 2007), (Mitsui, Tokuzawa et al. 2003)). 
The exact regulation of these transcription factors is crucial, as their over or under-
expression would affect ESC identity and differentiation state. Several studies mapping 
the genomic-binding sites of these core transcription factors revealed that these factors 
co-occupy the promoters of several transcription factors regulating their expression. 
Especially they bind to genes involved either in maintenance of pluripotency or in 
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establishing differentiation programs. The interaction with these promoters leads to 
differential regulation. On one hand it represses the transcription of genes involved in 
differentiation, on the other hand it maintains the active state of pluripotency-related 
genes. Interestingly the core pluripotency factors also co-occupy their own promoters and 
therefore are enhancing their own transcription enforcing the maintenance of pluripotency 
and self-renewal ((Boyer, Lee et al. 2005), (Loh, Wu et al. 2006)). 
 
3.1.2 The epigenetic state of ESC genome 
Since embryonic stem cells are competent to generate any cell type, a high level of 
genome plasticity is needed to rapidly establish a transcriptional program, allowing the 
selection of a specific direction of differentiation. In contrast to somatic cells, ESCs display 
an open chromatin structure. This finding suggests that the ratio between euchromatin 
and heterochromatin is higher and that the chromatin structure is less condensed than in 
differentiated cells (Bhattacharya, Talwar et al. 2009). A wide range of active histone 
marks like trimethylation of lysine 4 of histone H3 (H3K4me3), acetylation of lysine 27 of 
histone H3 (H3K27ac) and acetylation of histone H4 (H4ac), which contribute to keep 
chromatin accessibility, are associated with the euchromatic state of ESC genome 
((Azuara, Perry et al. 2006),(Gaspar-Maia, Alajem et al. 2011)). Despite the transcriptional 
permissive state of ESCs, in order to maintain pluripotency and genome stability, a certain 
degree of gene silencing must take place. For example, genes related to differentiation 
pathways are in a silent state due to the repressive histone mark trimethylation of lysine 
27 of histone H3 (H3K27me3). Also the transcription of sequences with a high mutagenic 
potential like retrotransposons must indeed be repressed (Reik 2007). It is interesting to 
note, that some of these genes are also marked with the active histone mark H3K4me3 at 
their promoter and for this reason have been defined as “bivalent” genes (Voigt, Tee et al. 
2013). These bivalent domains are suggested to poise expression of developmental 
genes hence allowing well-timed activation while maintaining repression in the absence of 
differentiation signals (Voigt, LeRoy et al. 2012). Therefore upon differentiation, most of 
the bivalent patterns of histone modifications are erased. In the case of induction of gene 
activation of specific lineage developmental genes, H3K4me3 is retained whereas 
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H3K27me3 is released. In the case of gene downregulation, H3K27me3 is retained 
whereas H3K4me3 is released (reviewed in (Gaspar-Maia, Alajem et al. 2011)). 
In contrast to developmental genes, which need to be loosely repressed, transposable 
elements for example must be completely and tightly repressed in order to avoid harmful 
genomic recombination events. This is achieved by H3K9 methylation and also by CpG 
methylation ((Bourc'his and Bestor 2004),(Schlesinger and Goff 2015)). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stem cell differentiation involve a major rearrangement of the epigenome that leads to the 
repression of pluripotency genes and activation of specific subsets of developmental 
genes according to the differentiation program that is activated (Meissner 2010). 
Noteworthy, ESC chromatin undergoes structural remodelling towards a highly condensed 
heterochromatic and transcriptionally repressed form upon differentiation (Bhattacharya, 
Talwar et al. 2009) (Figure 2). The open genome structure of embryonic stem cells clearly 
reflects the plasticity and the transcriptionally permissiveness of the ESC genome that has 
to have the ability to enter any distinct transcriptional program for lineage specification 
((Garneau, Dupuis et al. 2010),(Gorkin, Leung et al. 2014)). 
 
Figure 2 Chromatin during embryonic stem cell differentiation.  In pluripotent embryonic stem cells (left), chromatin is globally 
decondensed and enriched in active histone marks (green circular tags). Upon differentiation (right), large blocks of condensed 
heterochromatic region form and repressive histone marks (red circular tags). Image from (Meshorer and Misteli 2006) 
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3.2 DNA methylation 
Like histone methylation, DNA methylation plays a role in regulating gene expression of 
cells. It is a highly conserved epigenetic modification of the DNA, which occurs in 
prokaryotes as well as in eukaryotes. In higher eukaryotes DNA methylation generally 
occurs at 5’-position in a cytosine-phosphate-guanine (CpG) dinucleotide (Jones 2012). 
Large parts of vertebrate genome contain few CpG dinucleotides, which tend to be 
converted to 5-methylcytosines (5mC). Unmethylated CpGs are often found organized in 
clusters called CpG islands (CGIs) (reviewed in (Smith and Meissner 2013)). DNA 
methylation can change the structure of the DNA and can alter the binding of DNA binding 
proteins, which may therefore modulate transcription. It is considered as a mark of silent, 
inactive chromatin and is inversely correlated with gene activity (Jones 1999). Mammals 
use the methylation of CpG-rich promoters to prevent initiation of transcription and to 
ensure the silencing of genes for example on the inactive X chromosome, imprinted 
genes and parasitic DNAs (Jones and Takai 2001). In somatic tissues, CpG methylation 
shows global patterns based on relative CpG density: CpG islands at housekeeping or 
developmental promoters are largely unmethylated, whereas non-regulatory CpGs 
distributed somewhere else in the genome are mostly methylated, which therefore 
prevents transcription (Doerks, Copley et al. 2002). The acquisition of a genome wide 
program of CpG methylation is essential to determine the exit of the pluripotent state of 
ESCs and to start differentiation ((Gifford, Ziller et al. 2013),(Mohn and Schubeler 2009)). 
Cytosine methylation is carried out by a group of enzymes called DNA methyltransferases 
(DNMT) catalysing the transfer of a methyl group from S-adenosyl-methionine to CpG 
dinucleotides ((Tsai, Manor et al. 2010), (Jeltsch 2006)) (Figure 3). Methylation patterns 
are established de novo during embryonic development and stably inherited upon cell 
division. 
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Figure 3 Biogenesis of DNA methylation in eukaryotes. DNA methylation predominantly occurs at the fifth carbon atom of cytosine 
bases. Methylation is catalyzed by the de novo DNA methyltransferases DNMT3A and DNMT3B. During replication, After the passage 
of the replication fork, the maintenance DNMT, DNMT1, reestablishes CpG methylation on the newly synthesized strand hence 
allowing maintenance of the DNA methylation pattern over generations. Passive DNA demethylation is considered to be achieved 
across cell division in the absence of DNMT1 maintenance activity. The mammalian TET1–3 proteins have been condidered to play a 
role in active demethylation since they convert 5-mC to its oxidised derivative 5-hydroxymethylcytosine (5-hmC) and further to 5-
formylcytosine and 5-carboxylcytosine. These modifications are removed through DNA repair processes or are passively lost through 
replication. Image from (Ambrosi, Manzo et al. 2017) 
 
DNMT1 has been known as the enzyme responsible for maintenance of CpG methylation 
after replication (Bestor 2000). After the passage of the replication fork DNMT1 re-
establishes CpG methylation on the newly synthesized strand hence allowing 
maintenance of the DNA methylation pattern over generations (Hermann, Goyal et al. 
2004). De novo establishment of DNA methylation is performed by DNMT3a and 
DNMT3b, which are able to act on hemi-methylated but preferentially on unmethylated 
CpG-dinucleotides (Yokochi and Robertson 2002). It is known that all the DNMTs are 
essential for correct development in mouse and in human. Using homozygous mutants 
the role of DNMTs in ESCs has been analysed. De novo methylation in ESCs and mouse 
embryos is blocked through inactivation of genes encoding Dnmt3a and Dnmt3b. A 
double knockout of these genes is embryonic lethal in mouse, single KO leads to 
embryonic (Dnmt3b-KO) or postnatal (Dnmt3a-KO) lethality (Okano, Bell et al. 1999). 
Interestingly, in the same work Dnmt3a and Dnmt3b KO (dKO) ESCs have been obtained 
but they displayed absence of de novo methylation activity, suggesting that de novo 
methylation is actually needed later than blastocyst stage during embryonic development. 
Mutation of Dnmt1 gene results in embryonic lethality (Li, Bestor et al. 1992). Moreover 
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Dnmt1 KO ESCs maintain pluripotency but show elevated mutation rates and die shortly 
after being induced to differentiate ((Chen, Pettersson et al. 1998),(Jackson, Johnson et 
al. 2004)). These and other studies imply the importance of DNA methylation for 
maintaining genome stability, establishing and maintaining stable cellular identities, 
silencing transposable elements, genomic imprinting and X-chromosome inactivation (Wu 
and Zhang 2010). 
 
 
 
 
 
 
 
 
 
 
 
 
 
DNA methylation affects gene expression either via direct or indirect mechanisms    
(Figure 4). Some DNA binding proteins, as for example certain transcription factors are 
only able to interact with their target sequence if unmethylated. Therefore CpG 
methylation directly abolishes their interaction with the DNA and leads to lower 
transcription levels (Clark, Harrison et al. 1997). Furthermore methylated DNA can be 
recognized by a set of proteins called methyl-CpG-binding proteins (MBPs). It has been 
shown, that further factors, which mediate transcriptional repression such as histone 
deacetylases are recruited by these MBPs, leading to the establishment of silent 
chromatin at methylated CpG sequences (Defossez and Stancheva 2011). To ensure 
heritable change in chromatin structure the DNA methylation can be copied after DNA 
syntheses in somatic cells, although this process seems to be highly dynamic during 
Figure 4 DNA methylation of active and repressed genes. Binding of activators and/or increased CpG density protects promoters of 
active genes from DNA methylation. The lack of activators leads to DNA methylation at promoters of inactive genes. Direct or indirect 
interference of DNA methylation with activators at promoter regions of inactive genes leads to repression. This can occur for example via 
mCpG-dependent recruitment of repressors to methylated sites. Image from (Baubec and Schubeler 2014) 
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embryogenesis. The global DNA methylation is gradually reduced after fertilization until 
the implantation at the early blastocyst stage. The average level of CpG methylation is 
about 20% in early blastocyst cells of the ICM3.5. A major wave of DNA methylation 
occurs after implantation of the embryo. This process appears to be of importance in 
lineage restriction and cellular potency. At E6.5, the genome is hypermethylated with an 
average CpG methylation level of about ~70% ((Smith, Chan et al. 2012) and reviewed in 
(Marks and Stunnenberg 2014)). 
 
3.3 Nucleolus and ribosomal RNA (rRNA) genes 
The nucleolus is a well-defined, membrane-less nuclear subdomain, which appears as a 
dense structure in electron microscopy pictures. It is the nuclear compartment where 
ribosomal RNA is synthetized, processed and the assembly of ribosomes takes place. 
Ribosome biogenesis is initiated by the transcription of hundreds of ribosomal RNA (rRNA) 
genes (400 in mouse and human cells), which generate rRNA precursors (45S pre-rRNA, 
in mouse cells, 47S pre-rRNA in human cells). These transcripts are then later cleaved 
and processed into 28S, 18S and 5.8S rRNAs. To form the large and small ribosomal 
subunits, rRNA transcripts are assembled with ribosomal proteins (Santoro 2005). Since 
growing cells have an excessive demand for proteins, up to ten million ribosomes per cell 
are required. Therefore an average mammalian cell can produce as many as 10’000 
ribosomes/min. To meet the demand for this large-scale ribosome synthesis, cells have to 
invest a large part of their own metabolic effort. Thus it is crucial that cells keep the 
transcriptional activity of rRNA genes under tight surveillance to limit excessive energy 
consumption that could potentially deplete the cells from nutrients required for other 
essential processes. This is underlined by the fact that conditions that reduce cellular 
metabolism downregulate rRNA transcription (Moss 2004). Since the mammalian 
ribosome is made up of two-thirds RNA and one-third protein, this large-scale ribosome 
biogenesis forces cells to provide a large amount of rRNA. Thus it is not surprising that in 
mammalian cells, around 35% of nuclear transcription is committed to the production of 
rRNAs (reviewed in (Moss, Langlois et al. 2007)). 
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3.3.1 Structure of rRNA genes 
To meet the enormous amount of ribosomes needed in a living cell, an exclusive and 
potent transcription system was evolved. First by amplifying the numbers of rRNA genes 
to hundreds or even thousands of copies per genome and second by using a specific 
RNA polymerase (RNA polymerase I, Pol I). Interestingly rRNA gene units are teeming 
with polymerases and emerging transcript complexes, while on RNA Pol II genes rarely 
more than one isolated polymerase is active (Santoro 2011). 
The nucleolus results from the fusion of certain nucleolar organizing regions (Morin, 
Johnson et al. 2010). The human and mice genome contains about 400 copies of rRNA 
genes and each rRNA gene unit covers roughly 43kb in human and 45kb in mouse 
((Gonzalez and Sylvester 1995), (Grozdanov, Georgiev et al. 2003)) (Figure 5). These 
gene copies are organized into tandemly repeated clusters that are distributed among 
different chromosomes. While in mice, rRNA clusters are located within the centromeric 
regions of chromosomes 12, 15, 16, 18 and 19, the human rRNA genes are placed 
between the satellite body and the short arm of acrocentric chromosomes 13, 14, 15, 21 
and 26 ((Dev, Tantravahi et al. 1977),(Kurihara, Suh et al. 1994)). 
 
 
 
Long intergenic spacers (IGS) of roughly 30kb are separating one pre-rRNA gene from 
the next (13-14kb). The IGS sequence contains regulatory elements, including the main 
gene promoter, an alternative spacer promoter, repetitive enhancer elements and 
Figure 5 Organization of mouse rRNA genes. Upper panel shows the organization of one rRNA gene repeat. Scale bars (in kb) 
are shown below. 0 kb indicates the 5’ end of the pre-rRNA transcript. Lower panel represents the magnification of the regulatory 
region for transcription. The transcription initiation sites of the 45S pre-rRNA and transcripts from the intergenic spacer transcripts 
are shown with black arrows. Red boxes indicate terminator elements (T). The blue boxes exemplify repetitive enhancer elements 
located between the spacer promoter and the transcription start site (TSS) proximal core promoter element (CPE). The upstream 
control element (UCE) is also shown and is located upstream the TSS. The green dot represents the CpG at position -133 which is 
crucial for rDNA silencing through DNA methylation. Adapted from (McStay and Grummt 2008). 
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transcription terminators. The rRNA gene promoter contains two structure elements: the 
core promoter element bordering the transcription start site and roughly 100 nucleotides 
further upstream the upstream control element (UCE) ((Haltiner, Smale et al. 1986), 
(Learned, Learned et al. 1986)). One or more terminator elements that are recognized by 
TTF1 (transcription termination factor) are flanking the mammalian rRNA gene 
transcription units at their 5’ and 3’ ends. TTF1 is a specific DNA binding protein that 
stops the elongating Pol I and plays an important role in epigenetic regulation of rRNA 
genes. It appears that the major part of the IGS is devoid of regulatory elements, instead it 
comprises a high density of simple sequence repeats and transposable elements 
(reviewed in (Sylvester, Gonzales et al. 2004)).  
To transcribe rRNA genes, the formation of the pre-initiation complex on the promoter is 
necessary. This pre-initiation complex comprises the binding of the upstream binding 
factor (UBF) and the promoter selectivity factor (SL1 in humans, TIFIB in mice) ((Clos, 
Buttgereit et al. 1986), (Grummt 2003), (Moss, Langlois et al. 2007)). UBF stimulates the 
RNA pol I promoter escape and promotes transcriptional elongation and is therefore 
counteracting the repressive function of the heterochromatin protein 1 (HP1) at the rRNA 
genes ((Panov, Friedrich et al. 2006), (Kuhn and Grummt 1992), (Pelletier, Stefanovsky et 
al. 2000), (Stefanovsky, Langlois et al. 2006)). Thus UBF contributes in activating and 
promoting rRNA transcription through all these functions. Furthermore UBF binding to 
rRNA genes is impaired through methylation of the CpG at the position -133 inside the 
UCE resulting in transcriptional repression (Santoro and Grummt 2001). 
SL1/TIFIB is indispensable for the promoter specificity and contains the TATA box binding 
protein (TBP) and at least three Pol I- specific TBP-associated factors (TAFIs), 
TAFI110/95, TAFI68 and TAFI48 ((Comai, Tanese et al. 1992), (Zomerdijk, Beckmann et 
al. 1994), (Heix, Zomerdijk et al. 1997)). TAFIs play an important role in the assembly of 
the transcription complex, mediating specific interactions between the rRNA gene 
promoter and Pol I. They interact with UBF and by binding TIFIA they recruit Pol I to the 
rRNA gene. TIFIA is a basal regulatory factor that is associated with the initiation-
competent subpopulation of Pol I.  
At the 3’ end of each rRNA gene the terminators (T) are found in ten copies (T1-T10). 
They are involved in termination of transcription and in determining the direction of the 
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replication fork over the rRNA sequences. The T sequences are bound by TTF1 ((Grummt, 
Rosenbauer et al. 1986), (Gerber, Gogel et al. 1997)) 
Between the spacer promoter and the rRNA gene main promoter several repeated 
sequences are located that act as enhancer of rRNA transcription and are also bound by 
UBF (Pikaard, Pape et al. 1990). It has been shown that different variants of rRNA units 
exist according to the number of enhancer repeats (in mouse 6, 9, 10, 11, 12 and 22). The 
variation in rRNA sequences will be discussed in more details in chapter 3.3.6. 
 
3.3.2 Chromatin organization of rRNA genes 
Although cells contain many rRNA gene copies, not all the rRNA genes transcribe. Miller 
spreading analyses have shown two classes of rRNA genes: active genes, which are 
covered by elongating polymerases that synthesize rRNA and therefore show the 
characteristic tree-like appearance (DNA “trunk” from which closely packed 
ribonucleoprotein “branches” of increasing length extend) and silent genes, which are not 
associated with Pol I and hence are not transcribed. Therefore researchers proposed two 
ways how cells can regulate rRNA levels: (1) by controlling the transcription rate per gene 
by acting directly on the Pol I transcription machinery; (2) by regulating the number of 
genes to be transcribed (Santoro 2011) 
Psoralen is an intercalating drug that leads to DNA crosslink at sites that are not protected 
by nucleosomes. Recent studies using psoralen have shown that rRNA genes exist in two 
specific forms. rRNA genes which contain nucleosomes are not accessible to psoralen 
and thus represent inactive gene copies, whereas rRNA genes with a chromatin structure 
free of regularly spaced nucleosomes are accessible to psoralen and are therefore 
representing active gene copies, which are transcribed ((Lucchini and Sogo 1992), 
(Conconi, Widmer et al. 1989)). The relative amount of these two chromatin states is 
similar in both growing and resting cells as well as during interphase and metaphase, 
suggesting that these two chromatin structures are stably propagated throughout the cell 
cycle and are maintained independently of the transcriptional activity (reviewed in 
(Santoro 2005)). 
Studies demonstrated that also different epigenetic marks characterize the silent and 
active rRNA genes. Silent genes (inaccessible to psoralen) show more CpG methylation, 
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which is associated with heritable gene silencing and leads to a more heterochromatic 
structure. Active genes (rRNA genes accessible to psoralen) on the other hand miss this 
epigenetic mark, which suggests that rRNA gene methylation and repression of 
transcription are intimately linked (Stancheva, Lucchini et al. 1997). Later studies 
demonstrated a direct role of DNA methylation in repressing rRNA gene transcription. 
Treating mouse cells with 5-azacytidine, an inhibitor of cytosine methylation, increased 
pre-rRNA synthesis by 40-50%, suggesting that the lack of DNA methylation alleviates 
transcriptional repression of silent rRNA genes (Santoro 2005). A few crucial CpGs within 
the main rRNA gene promoter region seem to be critical for the repressive action of DNA 
methylation on rRNA transcription. Methylation of one specific CpG at -133 within the 
UCE (upstream control element) site impairs the binding of the Pol I transcription factor 
UBF (upstream binding factor) to rRNA gene chromatin. Consistent with this, methylation 
of one single HpaII site (CCGG) located in the rat promoter region of silent rDNA 
chromatin, showed a quite strong correlation with the repressed transcriptional state 
(Stancheva, Lucchini et al. 1997).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6 Model of active and silent rRNA genes. On the left side transcriptionally active rRNA genes are shown. They are 
characterized by open chromatin marked with active histone marks (Blue dots) and are bound by UBF and Pol I. On the right 
side the transcriptionally silent genes are shown. Typically they are in a compact heterochromatic structure marked with 
silencing histone marks (orange dots) and DNA CpG methylation (red dots). The pRNA dependent binding of TIP5 to rDNA 
promoters and the following recruitment of histone modifiers and DNA methyltransferases are responsible for the establishment 
of these repressive marks 
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The analysis of the composition of active and silent rRNA chromatin in higher eukaryotes 
and plants has been hampered for long time by the fact that rRNA genes have the same 
sequences. The identification of protein factors, including posttranslational modified 
histones, that bind either active (i.e. lack of meCpG) or to silent (i.e. enriched in meCpG) 
genes was only possible after the development of an assay based on chromatin 
immunoprecipitation (ChIP) combined with CpG methylation measurement (ChIP-chop) 
(Santoro, Li et al. 2002). Using this approach different studies found that the promoter of 
mouse and human active and unmethylated rRNA genes is associated with Pol I 
transcription factors and active histone marks (i.e. H4Ac and H3K4me2) (Santoro, Li et al. 
2002, Santoro and Grummt 2005) whereas silent and CpG methylated rRNA genes are 
associated with silent histone marks like H3K9me2, H3K27me3, H4K20me3 and the 
heterochromatin protein 1 (HP1) (Santoro, Li et al. 2002, Santoro and Grummt 2005) 
(Figure 6).  
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3.3.3 The nucleolar remodelling complex (NoRC) 
The nucleolar remodelling complex (NoRC) is the key player in establishing and 
maintaining the heterochromatic state of silent rRNA genes. The complex consists of TIP5 
(TTF1-interacting protein 5) and the ATPase SNF2h ((Santoro, Li et al. 2002), (Li, Santoro 
et al. 2005),(Strohner, Nemeth et al. 2001),  (Zhou, Santoro et al. 2002)) (Figure 6). 
SNF2h is the human homolog of the Drosophila ISWI whose ATPase activity is crucial for 
nucleosome remodelling. TIP5 was found in a yeast two-hybrid screening for TTF1 
interacting proteins (Strohner, Nemeth et al. 2001). TIP5, also known as BAZ2A is a 
member of the bromodomain adjacent zinc finger (BAZ) protein family (Jones, Hamana et 
al. 2000). It is the largest subunit of NoRC and shares a number of important domains 
with other components of nucleosome remodelling complexes such as ACF, WCRF, 
CHRAC and WICH ((Ito, Levenstein et al. 1999), (Bochar, Savard et al. 2000),(LeRoy, 
Loyola et al. 2000), (Bozhenok, Wade et al. 2002)). 
A bromodomain at the C-terminus allows the binding to acetylated histones and is 
required to mediate HDAC1 recruitment, SNF2h and other factors like HMTs and DNMTs 
bin a plant homeodomain (PHD) and a TAM (TIP5/ARBD/MBD) domain mediates the 
binding of RNA, in particular the stem loop structure of the lncRNA pRNA ((Zhou, Santoro 
et al. 2002),(Zhou and Grummt 2005), (Mayer, Schmitz et al. 2006)). There are further 
domains including a WAKZ motif, BAZ1 and BAZ2 motifs and several AT-hooks motifs.  
The recruitment of NoRC to the nucleoli is mediated by the transcription termination factor 
1 (TT1) ((Nemeth, Strohner et al. 2004, Mayer, Neubert et al. 2008), (Savic, Bar et al. 
2014)) that binds a sequence motif flaking the 5’ and 3’ ends of the rRNA gene 
transcription units (Olson 2011). Later the NoRC complex recruits the SIN3 co-repressor 
complex in a TIP5 dependent way leading to the deacetylation of nucleosomes at rRNA 
genes (Zhou, Santoro et al. 2002).  
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3.3.4  pRNA and the regulation of ribosomal genes 
The lncRNA pRNA is crucial for the epigenetic silencing of rRNA genes (Figure 6). pRNA 
is an approximately 200 nt long lncRNA that corresponds to the rRNA main promoter 
sequence. It is one of the few trans-acting lncRNA that have been known so far ((Lee 
2012), (Vance and Ponting 2014), (Froberg et al. 2014)). pRNA derives from the 
processing of intergenic spacer rRNA (IGS-rRNA). IGS-rRNA in turn is transcribed by Pol 
I starting at the alternative spacer promoter located around 2kb upstream of the main 
rRNA gene promoter and it spans the intergenic sequence including the main rRNA 
promoter sequences ((Mayer, Schmitz et al. 2006), (Santoro, Schmitz et al. 2010), (Savic, 
Bar et al. 2014)).  
It was shown that knockdown of pRNA induces loss of heterochromatin at rRNA genes in 
differentiated cell, suggesting the crucial role of this lncRNA (Mayer, Schmitz et al. 2006). 
pRNA forms a conserved hairpin structure that is essential to bind the TAM domain of 
TIP5 and to recruit the NoRC complex to rDNA promoters ((Mayer, Schmitz et al. 2006), 
(Savic, Bar et al. 2014)). 
Moreover the interaction of TIP5 with regulatory factors including PARP1 and TTF1 is 
mediated by pRNA, which acts as a scaffold through the stem loop structure. Moreover, 
pRNA acts as a guide for TIP5 to rRNA genes by promoting the association with TTF1 
((Mayer, Neubert et al. 2008), (Guetg, Scheifele et al. 2012), (Savic, Bar et al. 2014)). 
Recent studies have shown that mutating pRNA sequences involved in the stem loop 
structure formation abolishes TIP5-TTF1 interaction and therefore impairs the recruitment 
of TIP5 to rRNA genes (Savic, Bar et al. 2014). 
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3.3.5 Establishment of heterochromatin at rRNA genes 
Recent studies have shown that unlike in somatic cells all rRNA genes in ESCs are in an 
active state and devoid of heterochromatic marks (Figure 7) (Savic, Bar et al. 2014). This 
observation is remarkable as it is well known that the reduction of heterochromatin at 
rRNA genes in differentiated cells leads to genomic instability due to recombination 
events between the repetitive sequences ((Guetg, Lienemann et al. 2010), (Peng and 
Karpen 2007), (Straight, Shou et al. 1999)). Yet it is still unknown how stem cells can 
handle such a high risk of deleterious recombination events, which also include 
centromeric repeats and retrotransposons.  
It has been shown that the impairment of TIP5 association with rRNA genes is 
responsible for the lack of heterochromatin at rRNA genes in ESCs (Figure 7). Only upon 
differentiation TIP5 re-localizes within the nucleoli, where it binds and silences rRNA 
genes (Savic, Bar et al. 2014). The determinant for the impairment of TIP5 association 
and silencing of RNA genes in ESC is the lack of the processing of IGS-rRNA into the 
mature pRNA, a reaction mediated by the RNA helicase DHX9 (Leone, Bar et al. 2017)). 
In ESCs, the processing of IGS-rRNA into pRNA is impaired and activated only upon 
differentiation. Transfection of mature pRNA into ESCs was sufficient for the recruitment 
of TIP5 and formation of heterochromatin at rRNA genes, suggesting that maturation of 
IGS-rRNA into pRNA is crucial for the formation of heterochromatin in the nucleolus. 
Further experiments revealed that only the mature form of pRNA allows the association of 
TIP5 with TTF1 at rRNA gene promoter, whereas binding of TIP5 with the unprocessed 
IGS-rRNA transcript impairs this process (Savic, Bar et al. 2014). Therefore this study 
suggests that the recruitment of TIP5 to the rRNA genes occurs via a protein-RNA-
protein-DNA module.  
The formation of heterochromatin at rRNA genes appears to have a function that goes 
beyond the regulation of rRNA synthesis and ribosome biogenesis. The addition of mature 
pRNA in ESCs not only lead to rRNA gene silencing but also established highly 
condensed chromatin structures outside of the nucleolus, reminding of the genome 
organization that characterizes differentiated cells (Savic, Bar et al. 2014). This was 
accompanied by an increase of global levels of H3K9me2 as well as at the 
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heterochromatic repetitive sequences, such as major and minor satellites, as found in 
differentiated cells. Moreover, such heterochromatic ESCs were primed for differentiation 
due to upregulation of genes involved in differentiation and developmental processes 
(Savic, Bar et al. 2014). Hence these results suggest that the nucleolus is not only the 
cellular compartment of the ribosomal production but also of the heterochromatin 
establishment and is therefore affecting the genome architecture of the rest of the nucleus. 
Recent studies have revealed that the formation of heterochromatin at rRNA genes is 
required for ESC differentiation. Depletion of TIP5 or abrogation of IGS-rRNA processing 
through knockdown of DHX9 impairs ESC differentiation (Leone, Bar et al. 2017)). 
Remarkably, the differentiation defects of DHX9 depleted ESCs could be reverted by the 
addition of pRNA, whereas providing IGS‐rRNA and pRNA mutants deficient for TIP5 
binding are not sufficient. 
Taken together these results highlight an important function linked to the heterochromatic 
state of rRNA genes in orchestrating the remodeling of ESC genome from an open to a 
compacted structure and that this process is required to exit from pluripotency. 
 
 
Figure 7 Model of the establishment of heterochromatin at rRNA gene during ESC differentiation. The establishment 
of heterochromatin at rRNA genes depends on the processing of IGS‐rRNA into pRNA, a reaction mediated by DHX9 that is 
impaired in embryonic stem cells (ESCs) and activated only upon differentiation. The production of mature pRNA is essential 
since it guides the repressor TIP5 to rRNA genes, and IGS-rRNA abolishes this process. The cell cartoons represent the 
chromatin state of ESCs (open and euchromatic) and differentiated cells (closed and heterochromatic). The dark grey 
regions showed the presence of heterochromatic cluster characterizing differentiated cells. 
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3.3.6 rRNA gene variants  
As already described in 3.3.1, rRNA genes are clustered as tandem repeat units of 
roughly 44 kbp length, which are distributed among different chromosomes (in mouse 
cells, chromosomes 12, 15, 16, 18 and 19). In situ hybridization and cytogenetic studies 
showed that not all individual chromosomal rRNA gene loci are equally active in various 
cell types, leading to the suggestion that certain regulatory sub-domains might exist in the 
rRNA gene array and that they are regulated in a cell-type-specific manner (reviewed in 
(Tseng, Chou et al. 2008)). Early studies have shown that not all rRNA genes share the 
same sequences. Enzymatic digestion with the restriction enzymes EcoRI and HindIII 
showed heterogeneous patterns of restriction fragments in the non-transcribed spacer 
DNA among individuals such as BALB/c, C57BL and Mus poschiavinus strains and 
human leukemic blood cells (Arnheim and Southern 1977). Such a heterogeneous 
patterns of restriction fragments is clearly indicative of sequence variations among 
individuals. Importantly, analysis with restriction endonucleases EcoRI, HindIII and BamHI 
of rRNA genes in BALB/c strain revealed two, and possibly four, classes of repeating units 
and it was suggested that the rRNA gene heterogeneity within one individual probably 
resides in the very large non-transcribed spacer region (Cory and Adams 1977). A similar 
variation in sequence was also found in the spacer rRNA region from human placenta and 
it was suggested that unequal homologous exchange is the molecular basis for the 
observed length heterogeneity in the spacer rRNA sequences and may be a common 
mechanism for the generation of human genetic diversity (Erickson and Schmickel 1985). 
Studies in Xenopus laevis rRNA gene heterogeneity revealed variability in the copy 
numbers of a short repeated sequence of two regions within the non-transcribed spacer 
DNA (Wellauer, Dawid et al. 1976). In humans this variable region was observed by 
hybridizing Southern blots of BamHI digested genomic DNA with a probe specific for the 
3’-end of the 28S rRNA sequences. The presence of BamHI fragments of 6.0, 6.7, 7.6 
and 8.5 kb length is characterizing this variation. Interestingly the relative distribution of 
fragments within one size class is characteristic for individuals. Furthermore identical 
patterns of fragment size and distribution have been shown in different tissues from the 
same individual (reviewed in (Erickson and Schmickel 1985)). It has been suggested that 
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recombination between ribosomal genes might be responsible for both the sequence 
homogeneity of the transcribed gene and the length heterogeneity in the spacer region 
(Smith 1976). This restriction fragment length polymorphism (RFLP) was associated with 
a variable number of enhancer repeats located between the spacer promoter and the 
promoter-proximal terminator ((Arnheim and Kuehn 1979), (Tseng, Chou et al. 2008)). 
Comparison of these variants by cloning and sequencing indicated that mouse spacer and 
promoter sequences are identical but it is the number of enhancer repeats that varies 
(9,10,11,12 and 22 repeats) (Santoro, Schmitz et al. 2010). Remarkably, this work found 
evidences for the existence of regulatory sub-domains in the rRNA gene array. The 
analysis of IGS-rRNA length by RT-PCR has shown that IGS-rRNA is transcribed from a 
specific subclass of rRNA genes containing nine enhancer repeats (Santoro, Schmitz et 
al. 2010). As described in 3.3.5 chapter, transcription of IGS-RNA and maturation of 
pRNA is required for NoRC-dependent heterochromatin formation and transcriptional 
silencing. Therefore these findings suggest that a specific subclass of rRNA genes is 
involved in regulating gene silencing and nucleolar organization. Remarkably, recent 
studies have shown that rRNA genes can vary within the same individual not only for the 
length in the intergenic spacer but also for the presence of single nucleotide 
polymorphisms (SNPs). For example, a certain genetic variation has been described at 
position -104, where either a C or an A can be found (Shiao, Leighty et al. 2011). 
Interestingly, these SNPs appear to influence rRNA gene expression. Indeed, protein 
restricted diet during pregnancy lead to a specific CpG methylation at position -133 of -
104A-rRNA variant in the offspring, which correlates negatively with weaning weight 
(Holland, Lowe et al. 2016). Finally, a recent analysis revealed that in mouse cells rRNA 
genes contain a SNP (A or G or T) at +44 relative to transcription start site (Guetg, 
Lienemann et al. 2010). These studies taken together revealed inter and intra-
heterogeneity among rRNA gene sequences between individuals. However, the 
mechanisms by which this sequence variation influences gene transcription remain 
elusive.  
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4 Aims of the project 
As described in the previous section, establishment of epigenetic silencing at rRNA genes 
is developmental regulated. In embryonic stem cells (ESCs) all rRNA genes are 
transcriptionally active and only upon differentiation a fraction of genes undergo 
epigenetic silencing through methylation of the promoter sequence. Formation of 
heterochromatin at a fraction of rRNA genes is critical since abrogation of this process 
impairs ESC differentiation. Although the mechanisms by which this process is regulated 
during ESC differentiation are in large part understood, it still remains to clarify whether 
epigenetic silencing at rRNA genes is a random event (i.e. any rRNA gene can be 
epigenetically silenced) or whether a defined set of rRNA genes is specifically CpG 
methylated and transcriptionally repressed. 
Several evidences have started to indicate that rRNA genes do not share the exact same 
sequence. Sequence heterogeneity can be observed between individuals but also 
between rRNA sequences in the same individuals. Results from our and other 
laboratories have identified single nucleotide polymorphism (SNP) at position -104 and 
+44 relative to the transcription start site, indicating the presence of rRNA gene variants, 
which can be distinguished according to their SNP (-104C, -104A, +44A, +44G and +44T).  
The aim of this work was to determine whether genetic variation at rRNA genes can 
influence their epigenetic and transcriptional state. An important part of this project was 
the establishment of a method that allows the quantification of rRNA gene variants among 
individuals and determines their epigenetic and transcription state.  
This work describes the establishment of a SNP quantitative PCR, which efficiently 
distinguishes rRNA sequence variation and allows quantitative measurement of the 
amounts of rRNA gene variants present in several cell lines and tissue. Moreover, we 
adapted this method to analyse the epigenetic state of rRNA gene variants during 
embryonic stem cell differentiation.  
The results revealed different abundance of rRNA gene variants among individuals and 
determined that upon ESC differentiation rRNA gene silencing is not a random event but 
that certain rRNA gene variants are more prone to acquire CpG methylation. The results 
suggest that the genetic variation among rRNA sequences influences their epigenetic and 
transcription state. The development of this SNP specific quantitative PCR represents an 
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important tool for future studies aimed to dissect the crosstalk between genetic and 
epigenetic regulation at rRNA genes.   
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5 Material and Methods 
5.1 Material 
5.1.1 Cell lines 
Name Origin 
ESC+2i Mouse embryonic stem cells derived from 
mus musculus strain 129/Ola. 
ESC+serum Mouse embryonic stem cells derived from  
mus musculus strain 129/Ola.  
A kind gift for Prof. Ciaudo (ETH, Zurich) 
NIH 3T3 Mouse embryonic fibroblasts 
 
 
5.1.2 Medium for cell culture 
 Name  Composition 
 N2B27-medium  244 ml Neurobasal Medium  
 244 ml DMEM-F12 (Dulbecco’s Modified Eagle Medium,  Sigma)  
 2,5 ml N2 supplement 
 5 ml B27 supplement 
 5 ml Penicillin/Strep/Glutamine 
 0,5 ml Beta-Mercaptoethanol (100x, GIBCO) 
 FCS-medium  
 
 410 ml DMEM (Dulbecco’s Modified Eagle Medium, Sigma)  
 50 ml fetal calf serum 10 % 
 5 ml Penicillin/Streptomycin /L-Glutamine (Life technologies) 
 1 ml Beta-Mercaptoethanol (100x, GIBCO) 
 5 ml Non-essential Amino Acids (100x, Life Technologies) 
 5 ml Sodium-Pyruvate (100x, GIBCO) 
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 Complete medium  435 ml DMEM-F12 (Dulbecco’s Modified Eagle Medium, 
Sigma) 
 50 ml 10 % fetal calf serum  
 5 ml Sodium-Pyruvate (100x GIBCO) 
 5 ml Non-essential Amino Acids (100x Life Technologies) 
 0,91 ml Beta-Mercaptoethanol (100x, GIBCO) 
 5 ml Pen/Step/Glutamine (Life technologies) 
DMEM  Dulbecco’s Modified Eagle Medium, Sigma 
  
5.1.3  Buffers and solutions 
 Name  Composition 
 1x PBS buffer 140 mM NaCl 
2.7 mM KCl 
8.1 mM Na2HPO4 
1.5 mM KH2PO4 
pH 7.4 
Proteinase K digestion buffer 100 mM NaCl 
10 mM Tris-HCl pH8 
25 mM EDTA 
0,5 % SDS 
DNA loading buffer 30 mM EDTA 
30 % Glycerol 
0.5 % Bromophenol blue 
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5.1.4 Chemicals, enzymes, reagents and kits 
Name Company Further Information 
Trypsin-EDTA Gibco® Invitrogen 10x, 5 % Trypsin 
Penicillin/Streptomycin Life technologies 
10’000 U/ml Penicillin, 
10’000 µg/ml Streptomycin 
FCS Gibco® Invitrogen Fetal calf serum 
RNase A Fermentas 
DNase and protease-free,  
10 mg/ml 
Proteinase K Fermentas 21.2 mg/ml 
MgCl2 ApRoche 25 mM 
Primer random dN6 Roche 2 µg/m l 
dNTPs Fermentas 
dATP, dCTP, dGTP and dTTP; 
100 mM 
SYBR GREEN master mix Bioline 2x SensiMixTM SYBR Kit 
HpaII 
New England 
BioLabs 
10000 U/ml 
NEBuffer 3.1 
New England 
BioLabs 
 
Phenol:Chloroform:Isoamyl 
alcohol 
Sigma 25:24:1 
Ethanol Merck 100 % / 70 % 
Isopropanol Merck 100 % 
Agarose Promega  
Glycogen Roche 20 µg/µl 
Natrium acetate (NaAc)  Sigma 3 M, pH 5.5 
Natrium cloride (NaCl) Sigma 3 M 
Ethylenediaminetetraacetic 
acid (EDTA) 
Sigma 0.5 M, pH 8.0 
Sodium dodecyl sulfate 
(SDS) 
Sigma 10 % (w/v) 
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Diethyl dicarbonate DEPC Sigma  
Trizol Molecular Research 
Center,  
 
DNase I Fermentas 1 U/µl 
DNase I buffer Fermentas  
Reverse Transcriptase (RT) Roche 50 U/µl 
RT buffer Roche 100 mM Tris, pH 8; 500 mM KCl 
RiboLock RNase inhibitor Roche 40 U/µl 
Pfu DNA Polymerase Promega 2 U/ µl 
Pfu DNA Polymerase buffer Promega  
DpnI 
New England 
BioLabs 
 
DpnI digestion buffer 
New England 
BioLabs 
 
Buffer RES Macherey-Nagel 
For plasmid purification with 
NucleoBond® Xtra Maxi/Midi 
column 
Buffer LYS Macherey-Nagel 
For plasmid purification with 
NucleoBond® Xtra Maxi/Midi 
column 
Buffer EQU Macherey-Nagel 
For plasmid purification with 
NucleoBond® Xtra Maxi/Midi 
column 
Buffer NEU Macherey-Nagel 
For plasmid purification with 
NucleoBond® Xtra Maxi/Midi 
column 
Buffer WASH Macherey-Nagel 
For plasmid purification with 
NucleoBond® Xtra Maxi/Midi 
column 
Buffer ELU Macherey-Nagel 
For plasmid purification with 
NucleoBond® Xtra Maxi/Midi 
column 
Buffer C1 Qiagen 
For genomic DNA extraction with 
the Blood and Cell Culture DNA 
midi kit 
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Buffer RES Macherey-Nagel 
For plasmid purification with 
NucleoBond® Xtra Maxi/Midi 
column 
Buffer LYS Macherey-Nagel 
For plasmid purification with 
NucleoBond® Xtra Maxi/Midi 
column 
 
5.1.5 Equipment 
Name Company Further Information 
NanoDrop® 
NanoDrop technologies, 
Thermo Scientific ND-1000, Spectrophotometer 
PCR machine Applied Biosystems GeneAmp® PCR System 2720 
qPCR machine Corbett Research Rotor-Gene RG-3000 A 
 
5.1.6 Primers for quantitative PCR (qPCR) 
 Name 5.1.6.1.1 Sequence 5' !  3' 
 -165/-145 forward  
 
GACCAGTTGTTCCTTTGAGG 
 +111/+130 reverse 
 
GACAGCTTCAGGCACCGCGA 
 -105/-87 forward CCCAGGTATGACTTCCAG 
 -21/-1 reverse ACCTATCTCCAGGTCCAATAG 
 +1/+20 forward ACTGACACGCTGTCCTTTCC 
 +87/+66 reverse TAGGCTGGACAAGCAAAACAG 
 +550/+570 forward CTCTTGTTCTGTGTCTGCC 
 +745/+765 reverse GCCCGCTGGCAGAACGAGAAG 
 2409-2428 pBuescript forward CCTCCGATCGTTGTCAGAAG  
 2587-2606 pBuescript reverse CGCGGTATTATCCCGTATTG 
 2554-2573 pBuescript reverse GCAACTCGGTCGCCGCATAC 
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5.1.7 SNP primers for qPCR  
 Name Sequence 5' !  3' 
 +44A reverse TAAATCGAAAGGGTCTCTTT 
 +44G reverse TAAATCGAAAGGGTCTCTTC 
 +44T reverse TAAATCGAAAGGGTCTCTTA 
 -104C forward GTCATTTTTGGGCCACCTCCC 
 -104C reverse ATTACCTGGAAGTCATACCTGG 
 -104A forward GTCATTTTTGGGCCACCTCCA 
 -104A reverse AATACCTGGAAGTCATACCTGT 
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5.2 Methods 
5.2.1 Cell culture 
5.2.1.1 Culture conditions of embryonic stem cells 
Mouse embryonic stem cells were cultured in N2B27 or FCS medium at 37 ºC. For 
passaging, cells were first washed with 1x PBS and subsequentially incubated with 1x 
Trypsin for 2-3 min at 37 ºC. Cells were then collected in inhibitor-free medium and 
Trypsin was removed by centrifugation at 200 x g for 5 min. After supernatant was 
removed the cell pellet was resuspended in respective medium and 8000 cells/cm2 were 
seeded on cell culture dishes (Corning) coated with 0,1 % gelatin. 
 
5.2.1.2 Culture conditions of neural progenitor cells 
The differentiation of ESCs into neural progenitor cells (Bibel, Richter et al. 2004) was 
obtained using neural differentiation media (Complete medium). 27000 cells/cm2 were 
seeded on a not adherent plate (Greier) preventing them from attaching. During the 8-day 
differentiation procedure, media was exchanged every second day. For the last 4 days of 
differentiation the media was supplemented with 2µl retinoic acid (RA) to generate 
neuronal precursours. For changing the media the plates were tilt over so the cells were 
sinking to the bottom and the supernatant could be removed. 
 
5.2.2 Purification of genomic DNA 
About 300’000-500’000 cells were first washed with 1x PBS and subsequentially 
incubated with 1x Trypsin for 2-3 min. Cells were then collected in inhibitor-free medium 
and centrifuged at 1000 x g for 5 min. Cell pellet was then resuspended in 300 µl lysis 
buffer and 1,6 µl Proteinase K (20 mg/ml) was added. Samples were incubated at 50 °C 
over night. After cooling the samples down to 37 °C, 1 µl /ml RNase A was added for 1 
hour. Subsequently 300 µl Phenol:Chloroform:Isoamylalcohole (25:24:1) was added, 
samples were inverted and incubated for 5 min at room temperature. After centrifugation 
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at 7000 x g for 7 min at room temperature the aqueous phase was collected, 30 µl NaAC, 
0.5 µl. Glycogen and 210 µl Isopropanol were added and samples were incubated for 20 
min at -80 °C. Samples were then centrifuged with 20000 x g for 10 min at 4 °C, the 
supernatant was discarded; the pellet was washed with 500 µl Ethanol (70 %) followed by 
another centrifugation (20000 x g, 10 min, 4 °C). After discarding the supernatant pellets 
were dried at 50 °C for 3-5 min and resuspended in 40 µl water. 
Amount of genomic DNA (gDNA) was measured by spectrophotometer (Nanodrop). 
Quality and amounts of gDNA were also analysed by agarose gel electrophoresis. 
 
5.2.3 Enzymatic digestion of genomic DNA 
Enzymatic digestions were performed in 60 µl volume containing 4 µg of genomic DNA,  
5 ng pBuescript plasmid DNA, 1x Cut Smart Buffer (new England Bio Labs), 40 U HpaII 
(according to manufacture’s protocol). Reactions were incubated at 37 ºC over night 
slightly shaking. 100 µl Phenol:Chloroform:Isoamylalcohole (25:24:1) was added, samples 
were inverted and incubated for 5 min at room temperature. After centrifugation at 7000 x 
g for 7 min at room temperature the aqueous phase was collected, 10 µl NaAc, 0.5 µl 
Glycogen and 70 µl 100 % EtOH were added and samples were incubated for 20 min at -
80 °C. Samples were then centrifuged with 20000 x g for 10 min at 4 °C, the supernatant 
was discarded, the pellets were dried at 50 °C for 3-5 min and resuspended in 400 µl 
water. 
 
5.2.4 Quantitative PCR (qPCR) 
Quantitative PCR reactions were performed in 10 µl volume (1x SYBR GREEN master 
mix, 200 nM of respective primers). In case of RT-qPCR, quantification of gDNA was 
performed by amplification of 2 µl extracted/digested gDNA (10 ng/µl). Standard reactions 
were performed using the following thermal program: 10 min at 95 °C; 40-45 cycles of 20 
s at 95 °C, 30 s at 60 °C and 30 s at 72 °C; melting from 55 or 60 °C to 99 °C with steps 
of +1 °C. 
Quantifications were performed using standard curve, which represent serial dilutions of 
plasmid DNA (0.2 ng to 0.00002 ng).  
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5.2.5 RNA purification 
First cells were washed with 1 ml 1xPBS and pelleted at 1000 g for 5 min at 4 °C. 500 µl 
Trizol was added and tubes were incubated at room temperature for 5 min before 
centrifugation at 10600 x g for 5 min at 4 °C. The supernatant was transferred to a new 
1.5 ml Eppendorf, 100 µl chloroform was added and the samples were vortexed intensely 
for 15 s (until sample became turbid) and incubated at room temperature for another      
15 min. Subsequently the samples were centrifuged at 12000 x g for 15 min at 4 °C. The 
aqueous phase carrying the RNA was transferred into new Eppendorf tubes containing 
250 µl isopropanol. After mixing samples briefly they were placed at -80 °C for 15-20 min. 
For pelleting the RNA the samples were centrifuged at 13000 x g for 10 min at 4 °C. RNA 
pellets were then washed with 500 µl 75 % EtOH, dried and dissolved in 30 µl DEPC 
(diethylpyrocarbonate) treated H2O. After measuring RNA concentration by 
spectrophotometer (Nanodrop) samples were diluted to a concentration lower than      
3000 ng/µl. Samples containing less than 3000 ng/µl were brought up to a volume of     
44µl with DEPC treated H2O to which 5 µl DNase I buffer and 1 µl of DNase I was added. 
The samples were incubated at 37 °C for 1 h slightly shaking. The DNase I reaction was 
stopped by adding 500 µl Trizol and 100 µl chloroform, followed by vortexing intensely 
and incubating for 15 min at room temperature. After centrifugation at 12000 x g for        
15 min at 4 °C the aqueous phase was transferred to new Eppendorf tubes containing   
60 µl the NaAc pH 4.8 and 300 µl isopropanol. The samples were vortexed briefly and 
placed at -80 °C for 15-20 min. RNA was pelleted by centrifugation at 15000 x g for        
10 min at 4 °C, washed with 500 µl 70 % EtOH and dried. Finally the dried RNA pellet was 
dissolved in 20 µl DEPC treated H2O. 
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5.2.6 Reverse Transcription 
For reverser transcription the RNA samples were diluted to a concentration of 200 ng/µl 
and 1 µg of RNA was pipetted UltraFlux Flat Cap PCR tubes (Scientific Specialities Inc.) 
containing a reverse transcription mix consisting of the following TaqMan® Reverse 
Transcription Reagents (Roche): 
• 4,4 µl 25mM MgCl2  
• 2 µl 10x RT buffer 
• 4 µl dNTPs 2.5 mM 
• 0,25 µl RNase inhibitor (40 U/µl) 
• 1 µl 6mer primer 2.5 uM 
• 0,5 µl Reverse Transcriptase (50 U/µl) 
• DEPC treated H2O to fill up to a volume of 15 µl 
 
The PCR tubes were placed in the 2720 Thermal Cycler (Applied Biosystems) and the 
reverse transcription program was initiated (10 min at 25 °C, 60 min at 42 °C, 5 min at    
95 °C). 
 
5.2.7 Cloning 
5.2.7.1 Site directed mutagenesis 
 Mutations in rRNA gene sequences were generated by site directed mutagenesis. PCR 
reactions were performed in 20 µl volume and contained 20 ng plasmid DNA, 1x Pfu 
Polymerase buffer, 0.8 µl of respective primers, 200 µl of dNTPs, 1 U Pfu Polymerase. 
Amplification were performed using the following thermal program: 5 minutes at 95 ºC; 16 
cycles of 30 seconds 95 ºC, 1 minute 55 ºC, 15 minutes 72 ºC and then another 7 minutes 
at 72 ºC. To eliminate the original plasmids and select the mutated copies 10 U DpnI were 
added and samples were incubated at 37 °C for 30 min.  
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5.2.7.2 Transformation 
To transform bacteria with DpnI digested plasmid DNA, competent bacteria cells (DH5 
alpha Escherichia coli) were thawed slowly at 4 ºC. 10 µl of PCR reaction (see site 
directed mutagensis, 4.3.1) were added to 50 µl bacteria by gently mixing and kept a 4 °C 
for 10 minutes. Samples were heat-shocked for 45 seconds at 42 ºC and then placed on 
ice for 2 minutes. After addition of 500 µl LB medium, samples were incubated for one 
hour at 37 ºC, centrifuged at 1000 x g for 5 minutes. Pellet was resuspended in ca. 100 µl 
LB medium and plated on ampicillin agar plates over night at 37 ºC. The day after, 
colonies were picked and further cultured with 2 ml LB medium in the presence of 
ampicillin (100 µg/ml). 
 
5.2.7.3 Miniprep 
2 ml of over night-cultured bacteria were centrifuged (3000 x g, 10 minutes, 4 ºC) and 
bacteria pellet was resuspended in 250 µl resuspension buffer containing RNase A. 
Bacteria were lysed by adding 250 µl lysis buffer, gently mixed and incubated for              
4 minutes. 350 µl neutralization buffer was added, samples were inverted several times, 
and centrifuged for 10 minutes (20000 x g) at 4 ºC. Supernatants were collected and 
transferred into new Eppendorf tubes containing 420 µl isopropanol. Samples were 
vortexed, incubated for 10 minutes at -20 ºC s and centrifuged at 20000 x g for 10 minutes 
at 4 ºC. Pellet was air dried and then resuspended in 50 µl dH2O with shaking for 30 
minutes at 37 ºC. To identify correct clones 1.2 µg of plasmid were sent for sequencing. 
 
5.2.7.4 Midiprep 
120 ml of bacteria, cultured overnight at 37 °C, were centrifuged at 3000 x g for              
10 minutes and then resuspended with 8 ml of resuspension buffer in a 50 ml falcon. 
Bacteria were lysed by adding 8 ml lysis buffer. Samples were gently mixed and 
incubated for 5 minutes at room temperature. Reactions were neutralized by adding 8 ml 
of neutralization buffer by gently mixing. Lysates were poured on filters placed inside 
columns previously equilibrated with 12 ml equilibration buffer. Filters and columns were 
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then washed with 5 ml equilibration solution. After removal of filters, the column was 
washed with 8 ml of washing solution. Plasmid DNA eluted from column with 5 ml elution 
buffer was collected into a 15 ml falcon and precipitated by adding 3,5 ml isopropanol. 
Samples were left for 10 minutes at room temperature and then centrifuged for 45 min, 
4816 x g at 4 ºC. The DNA pellet was then resuspended in 500 µl TE buffer, transferred 
into a 2 ml Eppendorf tube, and again precipitated by adding 50 µl of NaAc and 1 ml of 
100 % Ethanol followed by vortexing, cooling for 1 h at -80 ºC and centrifugation at 20000 
x g for 10 minutes at 4 ºC. Pellet was air dried and then resuspended in 200 µl TE-buffer. 
DNA concentration was measured by Nanodrop. Samples were then diluted to 1 µg/µl 
plasmid DNA with TE-buffer and stored at 4 °C. 
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6 Results 
6.1 Establishment of a polymorphism specific quantitative PCR method to analyse 
rRNA gene variants 
As described in 3.3.6, accumulating evidences indicated that rRNA genes do not have the 
same exact sequence, showing different length in the intergenic regions such as the 
mouse enhancer repeat region as well as single nucleotide polymorphisms (SNPs) at 
position +44 (rRNA gene variants +44A/T/G) and -104 (rRNA gene variants -104C/A) 
((Wellauer, Dawid et al. 1976), (Holland, Lowe et al. 2016) (Guetg, Lienemann et al. 2010) 
(Santoro, Schmitz et al. 2010)). 
Early studies using restriction digestion followed by Southern blot hybridization have 
shown heterogeneous pattern among individuals, suggesting that the distribution of 
fragments within one size class is characteristic for individuals. Remarkably, identical 
patterns of fragment size and distribution were also found the same individual (reviewed 
in (Erickson and Schmickel 1985)), providing a first indication rRNA sequence 
heterogeneity within the same genome. The restriction fragment length polymorphism is 
associated with a variable number of enhancer repeats (9, 10, 11, 12 and 22), which 
seems to be a regulatory sub-domain in the rRNA gene array. Indeed, Santoro et al. 
showed that the long non-coding RNA IGS-rRNA is transcribed from a specific subclass of 
rRNA genes containing nine enhancer repeats (Santoro, Schmitz et al. 2010). Since 
transcription of IGS-RNA and maturation of pRNA is required for NoRC-dependent 
heterochromatin formation and transcriptional silencing (Savic, Bar et al. 2014), it has 
been suggested that specific subclasses of rRNA genes are involved in the regulation of 
rRNA gene silencing and nucleolar organization.  
In this work, we aimed to determine whether rRNA gene variants containing different 
SNPs are distributed differently amongst individuals and if they might have a certain 
regulatory function, such as the regulation of epigenetic and transcriptional state. For this 
analysis, it was necessary to establish a quantitative system to measure the SNPs at +44 
(rRNA gene variants +44A/T/G) and at -104 (rRNA gene variants -104A/C). We 
approached this goal by using quantitative PCR (qPCR) and the establishment of primers 
that specifically amplify rRNA variants containing the corresponding polymorphism (rRNA 
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gene variants +44A/T/G, -104A/C). Since the amplification efficiency can vary among 
different primer pairs, it was important to establish a method that also takes into account 
these possible variations. To do this, I quantified the absolute amounts of amplified rRNA 
gene variants using as standard curve serial logarithmic dilutions of plasmids containing 
the 5'-region of the corresponding rRNA gene variants, which contained the specific SNP 
sequence (+44A/T/G and -104A/C). Since we were unable to clone all the rRNA variants 
and their combination directly from genomic DNA, we applied site directed mutagenesis 
on existing plasmid containing rRNA promoter sequences to obtain the complete series of 
rRNA variants (-104C/+44A (CA), -104C/+44T (CT), -104C/+44G (CG), -104A/+44A (AA), 
-104A/+44T (AT), -104A/+44G (AG)). The standard curves were obtained through 
logarithmic dilutions, starting from a plasmid concentration of 100 ng/µl, which was 
measured by spectrophotometer (Nanodrop). The dilution series comprised 8 dilution 
steps, ending to a concentration of 0.00001 ng/µl. The initial plasmid DNA concentration 
was obtained by measuring DNA absorbance. However, this method is quite imprecise for 
our purpose. Therefore, the amounts of DNA in all the rRNA gene variants standard 
samples were further assessed by quantitative PCR using primer pairs encompassing a 
rRNA sequence, which does not contain a polymorphism (-165 forward and +111 reverse, 
Figure 8). In these measurements, we set the values of the concentration of plasmid 
containing the rRNA gene variant -104C/+44A (CA) as true (sample 1, 100 ng/µl ) and 
used the serial dilutions of this DNA as standard curve for all the other samples. As shown 
in Table 1, the concentration of rRNA gene variants -104A/+44A (AA), (-104A/+44G (AG) 
and -104A/+44T (AT) were the same as the samples containing rRNA gene variant -
104C/+44A (CA). In contrast, the samples containing rRNA gene variants -104C/+44G 
(CG) and -104C/+44T (CT) had higher concentration (sample 1, 200 ng/ml and 150 ng/ml, 
respectively). As described below, the results obtained from the comparative 
quantifications of all rRNA gene standards will allow to quantify the amounts of rRNA 
gene variants present in cells.  
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Figure 8 Strategy for the amplification of mouse rRNA gene variants. The respective rRNA polymorphism at position -104 
and +44 are marked as well as the CpG sites at position -133 and -142. Arrows represent the primers used for amplification. 
Black arrows indicate primers that do not encompass sequences with SNPs. Color arrows represent SNP specific primers. At 
position -142 the analyzed HpaII site is marked. 
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Name of Standard 
sample 
Concentration 
(ng/µ l) 
Name of Standard 
sample 
 
Concentration 
(ng/µ l) 
 
CA1 (-104C/+44A) 100.0 AA1 (-104A/+44A) 100.0 
CA2 10.0  AA2 10.0  
CA3 1.0  AA3 1.0  
CA4 0.1  AA4 0.1  
CA5 0.01  AA5 0.01  
CA6 0.001  AA6 0.001  
CA7 0.0001  AA7 0.0001  
CA8 0.00001  AA8 0.00001  
CG1 (-104C/+44G)  200.0  AG1 (-104A/+44G)  100.0  
CG2 20.0 AG2 10.0  
CG3 2.0 AG3 1.0  
CG4 0.2  AG4 0.1  
CG5 0.02  AG5 0.01  
CG6 0.002  AG6 0.001  
CG7 0.0002  AG7 0.0001  
CG8 0.00002  AG8 0.00001  
AT1 (-104A/+44T)  100.0  CT1 (-104C/+44T)  150.0  
AT2 10.0  CT2 15.0  
AT3 1.0  CT3 1.5  
AT4 0.1  CT4 0.15  
AT5 0.01  CT5 0.015  
AT6 0.001  CT6 0.0015  
AT7 0.0001  CT7 0.00015  
AT8 0.00001  CT8 0.000015  
 
 
Table 1 Quantification of rRNA gene variants in standard samples. Plasmids are named according to SNPs at -104 and +44 at 
rRNA sequences. The first capital letter indicated the nucleotide matching the rRNA gene variant at position -104 whereas the second 
letter describes the nucleotide matching the rRNA gene variant at position +44. All values were obtained using technical triplicates. 
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To quantify the different rRNA gene variants, we aimed to generate highly specific primer 
pairs that amplify exclusively the respective variants. To do so, we reasoned that the 
complementarity of the last nucleotide at 3’ end of each primer should have been key for 
the specific amplification of each rRNA gene variant since any nucleotide mismatch at 
primer/DNA template hybrid compromises the polymerase activity of the Taq enzyme. To 
assess primer specificity, we first tested the respective primer pairs using positive and 
negative controls (Figure 9). As a positive control, I used a plasmid containing the 
respective polymorphism in the rRNA sequence. As shown in Figure 9A, 0.2 pg of plasmid 
CA (SNPs at -104C and +44A) was used to test the specificity of the reverse +44A primer, 
which contains a T nucleotide at the 3’ of its sequence. As negative controls, I used the 
same amount of plasmids CG (SNPs -104C and +44G) and AT (SNPs -104A and +44T), 
which do not contain the A nucleotide at position +44 in their sequence. The forward 
primer I used to amplify this sequence encompasses the sequence at position -165 which 
does not vary amongst rRNA gene variants (Figure 9A). The results indicated that the 
plasmid CA was efficiently amplified (green bar) whereas amplifications of 0.2 pg plasmid 
containing G and T SNPs at +44 (red bars) were much less efficient (less than 10 fold). 
Thus, we concluded that the +44A primer specifically amplifies rRNA gene variant +44A. I 
used the same strategy to assess the specificity of all other primers. As shown in Figure 
9B-C, the reverse primers +44G and +44T efficiently amplify the corresponding variants 
(+44G and +44T) but not the other rRNA sequences, indicating specificity in the 
amplification according to the SNP at +44. I also analysed the specificity of primers for the 
amplification of rRNA variants containing C or A at -104 site. The amplification with the 
reverse primer -104C was assessed using the forward primer -165, which as described 
above encompasses sequence lacking SNPs, and 0.2 pg of plasmid DNA containing -
104C rRNA gene variant. As shown in Figure 9D, the reverse primer -104C only amplifies 
the corresponding 104C variant whereas amplification from the same amount of the other 
rRNA genes variants were not as efficient. Finally, I analysed the specificity of 
amplification for the forward -104A primer using the reverse primer -21, which 
encompasses sequence lacking SNPs, and 0.2 pg of plasmid DNA containing -104A 
rRNA gene variant. Also this primer showed high specificity toward the -104A variant 
(Figure 9E).  
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Figure 9 Analysis of primers for the specific amplification of rRNA genes containing single nucleotide 
polymorphisms at position -104 and +44. (A) Upper panel shows the primers used to amplify the rRNA sequence with 
SNP +44A. Bottom panel shows qPCR measurements of 0. 2 pg plasmid DNA containing the polymorphisms A (green bar) 
or G or T (red bars). Values were obtained using the standard curve with rRNA gene variant +44A. Each samples was 
measured in triplicate. Amplification with reverse primers +44G (B), +44T (C), -104C (D) and forward primer -104A (E) are 
shown. Green bars represent values of measurements for the chosen SNP whereas red bars represent values of 
amplifications of sequences that do not correspond to the SNP. 
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Unfortunately, the forward primer -104C and the reverse primer -104A did not pass the 
criteria we set for specific SNP amplification. As shown in Figure 10A, the reverse primer 
-104C can amplify equally well plasmid CA (rRNA gene variant -104C and +44A) and 
three other plasmids containing the -104A SNP. Similarly, the reverse -104A primer can 
amplify equally well the plasmid AT (rRNA gene variant -104A and +44T) and three other 
plasmids containing the -104C SNP. Since these primers did not meet the criteria for 
primer SNP specificity they were excluded from all further analyses.  
 
 
 
 
  
Figure 10 Analysis of primer pairs for single nucleotide polymorphisms at position -104. (A) Upper panel shows the primers 
used to amplify the rRNA sequence with SNP -104C. Bottom panel shows qPCR measurement of 2 and 0.2 pg plasmid DNA 
containing the polymorphisms -104C (green bars) or -104A (red bars). Values were obtained using the standard curve with rRNA gene 
variant -104C, +44A (CA). Each sample was measured in triplicate. (B) Upper panel depicts the primers used to amplify the rRNA 
sequence with SNP -104A. Bottom panel shows qPCR measurement of 2 and 0.2 pg plasmid DNA containing the polymorphisms -
104A (green bars) or -104C (red bars). Values were obtained using the standard curve with rRNA gene variant -104A, +44T (AT). 
Each samples was measured in triplicate. 
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6.2 Distribution of single nucleotide polymorphisms in different cell lines 
The establishment of a SNP specific qPCR represents an important tool to identify and 
quantify the different rRNA gene variants and to determine the rRNA gene heterogeneity 
between different individuals and within the same individuals. With this aim, I analyzed the 
following cell lines and tissues: ESCs cultured in 2i/LIF (ESCs+2i, a cell line currently in 
use in the Santoro laboratory), ESCs cultured in serum/LIF (ESCs+serum, a kind gift of 
Constance Ciaudo, ETH Zurich), mouse embryonic fibroblast cells (NIH3T3) and tissues 
obtained from phalangeal biopsies of C57BL/6 mice (C57BL/6-tissue). It is to note that the 
two embryonic stem cell lines share the same genetic background since they both derive 
from the mus musculus strain 129/Ola.  
I isolated genomic DNA and analyzed the amounts of rRNA gene variants using the SNP 
specific primers described in section 6.1 (Figure 8). To ensure the specificity of the 
primers in recognizing the correct variants, all the amplifications have been performed 
with plasmids containing the corresponding rRNA gene variant (positive control) and 
rRNA gene variants with other SNPs at the same position (negative control). Since the 
amplification efficiency of different primer pairs can vary, we calculated the values 
according to the standard curves, which represent serial dilutions of different plasmid DNA 
(Table 1). Using the standard curves described in section 6.1 the obtained values enabled 
us to analyze absolute amounts of rRNA variant/sample, the sum of which represents the 
total amount of rRNA genes. To increase the accuracy of the results, all the samples were 
measured in triplicates. 
The data obtained from these measurements revealed that the rRNA variants are indeed 
differently distributed among different cell lines. Analyses of SNP at +44 site (Figure 11A) 
indicate that in ESCs+2i the +44A-rRNA variant is the most abundant one (49.5%) 
whereas +44T-rRNA sequence is the least frequent variant (13.9%). The amount of 
+44G-rRNA variant (36.4%) is comparable to the amount measured in ESCs+serum 
(35.1%). Interestingly, ESCs+serum lack the +44T-rRNA variant. The absence of +44T-
rRNA variants in ESCs+serum line is an unexpected result since both ESC lines derive 
from the same mouse strain and hence must have the same genotype. As discussed in 
the Discussion chapter, we reason that during culturing the ESCs+serum line underwent 
genome instability such as the loss of one or more chromosomes or deletion of defined 
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regions. A karyotype analyses of these cells is currently on going. The In C57BL/6-tissue 
all three variants containing the +44-SNP are present in comparable amounts (44A-rRNA: 
35.5%, +44G-rRNA: 28.6%, +44T-rRNA: 36%). In contrast, in NIH3T3 cells, the +44A-
rRNA variant is less abundant (21.9%) than +44G-rRNA (38%) and +44T-rRNA (40%), 
which are almost equally represented (Figure 11A). 
Quantification of rRNA gene variants containing SNPs -104C and -104A revealed 
unexpected results (Figure 11B). Both ESCs+2i and ESCs+serum lack the -104A-rRNA, 
suggesting the existence of only a limited combination of -104 and +44 SNPs among the 
rRNA genes. We therefore conclude that ESCs+2i contain three types of -104/+44 
variants (-104C/+44A (CA), -104C/+44T (CT) and -104C/+44G (CG) whereas 
ESCs+serum contain only two -104/+44 rRNA variants: -104C/+44A (CA) and -
104C/+44G (CG)). In contrast, we found the presence of both SNPs A and C at -104 in 
C57BL/6-tissue and NIH3T3 cells. The -104A-rRNA variant is less abundant (C57BL/6: 
38.2%, NIH3T3: 34.6%) than the -104C rRNA variant (C57BL/6: 61.8%, NIH3T3: 65.4%) 
(Figure 11B). Thus, in C57BL/6-tissue and NIH3T3 cells rRNA genes are possibly 
present in six different combinations of -104 and +44 SNPs (rRNA variants -104C/+44A 
(CA), -104C/+44T (CT), -104C/+44G (CG), -104A/+44A (AA), -104A/+44T (AT), -
104A/+44G (AG). 
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Figure 11 Quantification of -104 and +44 SNP distribution in cell lines and tissues. (A) Upper panel shows the primers used to 
amplify rRNA sequences with SNP +44. Bar chart shows the abundance of +44A, +44G and +44T rRNA variants. Values represent 
relative amounts of the respective variants normalized to the total amount of rRNA genes calculated as the sum of the +44 variants 
amounts. (B) Upper panel depicts the primers used to amplify the rRNA sequence with SNP -104. Bar chart shows the abundance 
of -104A and -104C rRNA variants. Values represent relative amounts of the respective variants normalized to the total amount of 
rRNA genes as indicated in A. 
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6.3 Methylation of rRNA variants upon embryonic stem cell differentiation 
As described in 3.3.3, upon differentiation of embryonic stem cells (ESCs) a fraction of 
rRNA genes undergoes silencing through epigenetic modifications mediated by the 
nucleolar repressor TIP5, a component of NoRC complex (Savic, Bar et al. 2014). In 
differentiated cells TIP5 is targeted to rRNA gene promoter and recruits DNA 
methyltransferases with consequent establishment of de novo methylation at rRNA genes 
((Savic, Bar et al. 2014),(Leone, Bar et al. 2017)). Formation of heterochromatin at a 
fraction of rRNA genes is critical since abrogation of this process impairs ESC 
differentiation (Leone, Bar et al. 2017). Although the mechanisms of how this reaction is 
achieved are quite well understood, it still remains to clarify whether epigenetic silencing 
at rRNA genes is a random event (i.e. any rRNA gene can be epigenetically silenced) or 
whether a defined set of rRNA genes is specifically CpG methylated and transcriptionally 
repressed. 
The results described in the previous sections determined that rRNA genes do not share 
the exact same sequences. We reasoned that the identification and quantifications of 
SNPs at +44 (+44A/T/G rRNA gene variants) and at -104 (-104A/C rRNA gene variants) 
will allow us to learn whether a defined class of rRNA genes is more prone to acquire 
DNA methylation upon ESC differentiation. To measure DNA methylation state at specific 
rRNA gene variants, we applied a strategy based on the measurement of resistance to 
the digestion of the restriction enzyme HpaII (Figure 12A). The sequence CCGG is 
recognized by HpaII. However, HpaII digestion is blocked by CpG methylation. Upon 
digestion of genomic DNA with HpaII, the use of primers encompassing the CCGG site 
allows the amplification and subsequent quantification of HpaII resistant and therefore 
methylated sequences. Amplification of sequences lacking CpGs allows the measurement 
of total DNA, which is then used to calculate the proportion of methylated sequences. The 
mouse rRNA gene promoter contains two CpGs sequence at -142 and -133 which are 
both methylated at silent rRNA genes (Santoro and Grummt 2001). CpG dinucleotide at -
142 is within the sequence CCGG, which can be digested by HpaII (Figure 12B). 
Therefore, resistance to HpaII digestion at the rRNA promoter sequences is indicative of 
CpG methylation and this can be measured by quantitative PCR using appropriate 
primers (Santoro, Li et al. 2002). The proportion of methylated rRNA sequences can be 
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then measured through normalization of total rRNA sequences obtained with the 
amplification with primers amplifying the rRNA region from -105 to -1, which lacks CpG 
residues. To assess equal digestion between samples, we included a further control 
based on the digestion of pBluescript plasmid DNA, which does not contain methylated 
CpGs. In each sample genomic DNA and pBluescript were mixed together and incubated 
with HpaII. The digestion efficiency of pBluescript DNA was calculated through 
amplification with a primer pair encompassing CCGG sequences (from 2409 to 2587) and 
normalized to regions lacking HpaII sites (from 2409 to 2544, Figure 12C).  
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Figure 12. Strategy to measure methylation of rRNA genes. (A) Schema depicts the rationale for the measurement of DNA 
methylation via the assessment of resistance to the digestion of the restriction enzyme HpaII by quantitative PCR. (B) Schema of 
the rRNA promoter. The HpaII digestion site CCGG is marked at position -142. Black arrows represent the primer pairs used for 
the amplification. Formula shows how the amounts of methylated total rRNA promoter sequences are calculated (%). (C) 
Schema of the sequence of pBluescript plasmid. The HpaII digestion site is marked at position 2580. Blue arrows represent the 
primer pairs used for amplification. Formula shows how the amounts of undigested pBluescript sequences, which represents 
HpaII digestion efficiency, are calculated (%). 
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We initially measured the amount of CpG methylation at total rRNA genes in ESCs and 
upon differentiation of ESCs into neural progenitors (NPCs). To generate NPCs we used 
an established protocol (Bibel, Richter et al. 2004) where ESCs growing in 2i/LIF 
(ESCs+2i) or serum/LIF (ESCs+serum) were cultured with a neural differentiation media 
on a not adherent plate. After 4 days culture, cells were grown in the presence of retinoic 
acid (RA) for further 4 days. As shown in Figure 13, NPCs form cellular aggregates 
(embryonic bodies) that grow in suspension. 
  
 
 
 
 
 
 
 
 
 
 
To measure DNA methylation at rRNA genes, we performed HpaII digestion of purified 
genomic DNA from ESCs+2i, ESCs+serum, and the corresponding derived NPCs 
(NPCs/2i and NPCs/serum). To assess an equal efficiency of HpaII digestion among 
samples, each genomic DNA was digested in the presence of unmethylated pBluescript 
plasmid. Efficiency of HpaII digestion was measured by calculating the amounts of 
undigested pBluescript sequences using primers encompassing the HpaII site at position 
2580  (Figure 12B). As shown in Figure 14A, our experimental conditions allowed a high 
efficient HpaII digestion, which was very similar among all treated samples (ESCs+2i: 
99.6%, NPCs/2i: 99.9%, ESCs+serum: 99.7% and NPCs/serum: 99.7%).  
Figure 13 Representative pictures of (A) embryonic stem cells (ESCs) stained for alkaline phosphatase (AP) and (B) neural 
progenitor cells (NPCs). 
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As described in 3.2, the genome of the inner cell mass (ICM) cells contains low levels of 
DNA methylation (Smith, Chan et al. 2012). Similarly, derivation of ESCs from ICM 
through culturing with 2i allows the establishment of a in vitro ground state which 
coincides with a hypomethylated genome. In contrast, ESCs cultured in serum showed 
high CpG methylation levels (Marks and Stunnenberg 2014). We initially analysed the 
CpG methylation content of total rRNA genes in ESCs and NPCs (Figure 14). We found 
that only few rRNA genes (2.72%) in ESCs+2i are methylated, which is consistent with 
recent results showing that the low methylation content in ESCs+2i is due to the down 
regulation of the de novo methyltransferases DNMT3b and DMNT3a ((Leitch, McEwen et 
al. 2013),(Ficz, Hore et al. 2013)) (Figure 14B). Remarkably, also in the case of 
ESCs+serum, which contain elevated CpG methylation due to elevated Dnmt3a and 
Dnmt3b expression levels, only very few rRNA genes are methylated (0,8%), supporting 
an important role in the maintenance of rRNA genes in a hypomethylated state that is 
linked to the pluripotency state as recently suggested by (Leone, Bar et al. 2017). 
Consistent with previous results (Savic, Bar et al. 2014), upon differentiation into NPCs, a 
fraction of rRNA genes acquires epigenetic silencing through CpG methylation. As shown 
in Figure 14B, both NPCs derived from ESCs+2i and from ESCs+serum showed de novo 
methylation at a fraction of rRNA genes, 20.2% and 23.7% respectively. These values are 
very similar to the levels of rRNA gene methylation recently reported in mouse brain 
Figure14 rRNA genes undergo CpG methylation upon ESC differentiation into NPCs. (A) Efficiency of HpaII digestion 
measured by amplifications of pBluescript sequences as indicated in Figure 12C. (B) Methylation of rRNA genes in ESCs+2i, 
NPCs/2i, ESCs+serum, NPCs/serum obtained through the amplification of genomic DNA digested with HpaII.  Values were 
obtained by normalizing the amounts of methylated, HpaII resistant rRNA genes sequences to total rRNA genes as shown is 
Figure 12B. Measurements of amplified sequences were calculated using a series of logarithmic dilutions of pBluescript 
plasmid and plasmids containing RNA gene sequences (see Table 1). 
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tissues (30%) (Savic, Bar et al. 2014), underscoring a functional link between the 
establishment of CpG methylation at rRNA genes and early development. 
The results shown in the previous sections determined the existence of certain rRNA 
gene subclasses, which do not share the same sequences (rRNA gene variants +44A/T/G 
and rRNA gene variants -104A/C). These rRNA gene variants showed a distinct 
distribution pattern in different cell lines (Figure 11). To determine whether a defined set 
of rRNA genes is specifically CpG methylated and transcriptionally repressed upon ESC 
differentiation, we measured DNA methylation levels of the different rRNA gene variants 
in ESCs and NPCs, applying the experimental strategy shown in Figure 15A. Because of 
the lack of a SNP at -104 in both analyzed ESC lines, all measurements were performed 
on +44 rRNA gene variants. Genomic DNA from the two ESC lines (ESCs+2i and 
ESCS+serum) and the derived neural progenitors (NPCs/2i and NPCs/serum) were 
digested with HpaII and the amounts of CpG methylated +44 A/T/G-rRNA variants were 
obtained by quantitative amplifications using the forward -165 primer and the reverse +44 
SNP reverse primers. These values were then normalized to the total amount of rRNA 
quantified through amplifications of rRNA sequence lacking SNPs using forward -105 and 
the -21 reverse primers (Figure 15). 
In these experiments, we detected 5.7% methylation in ESCs+2i, which was mostly 
present at +44G variant whereas +44A and +44T variants were not methylated (Figure 
15C). Interestingly, although the +44A variant is the mostly abundant in this ESC line 
(49.5% of total rRNA genes, Figure 15B), upon differentiation into NPCs it acquires less 
de novo methylation (9.1%) compared to the other variants (+44G-rRNA: 16.3% and 
+44T-rRNA: 17.9%) (Figure 15B,C). On the other hand, the +44T-rRNA variant, which is 
the least abundant variant (14%) in ESCs+2i, seems to be more prone to acquire CpG 
methylation upon differentiation (17.9%) than the other rRNA gene variants. As described 
in section 6.2, the cell line ESC+serum lacks the +44T-variant (Figure 15D). Analysis in 
ESCs+serum revealed very low and comparable levels of DNA methylation at +44A (1%) 
and +44G-rRNAs (1.3%) (Figure 15E). Upon differentiation into NPCs, although the +44A 
variant is almost 2-fold more abundant than +44G variant (64.5% of total rRNA genes), it 
contributes to DNA methylation only for 9% whereas methylated +44G-rRNAs represent 
15.9% of methylated sequences. Taken together these results indicated that +44A-rRNA 
genes are less prone to be methylated whereas +44G and +44T-variants are the major 
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targets for de novo methylation. These data strongly indicate that upon ESC differentiation 
methylation at rRNA genes is not randomly distributed but some rRNA gene variants are 
more prone to acquire CpG methylation.  
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Figure 15 Distribution of CpG methylation at rRNA variants during ESC differentiation. (A) Left panel depicts primers 
used to amplify +44-rRNA variants and the strategy to measure methylation at -142. Right panel shows the example of how 
methylation levels at +44A-rRNA genes were calculated. In this case, the amounts of +44A-rRNA sequences resistant to HpaII 
digestion (i.e. methylated at CpG -142) obtained through amplifications with primers 1 (P1) and +44A primer 2 (P2A) were 
normalized to total amount of rRNA genes using primer 3 (P3) and primer 4 (P4) (B) Bar chart shows the abundance of +44A, 
+44G and +44T rRNA variants in ESCs+2i. Values represent relative amounts of the respective variants normalized to the total 
amount of rRNA genes calculated as the sum of the +44 variants amounts. (C) Methylation levels at rRNA variants in ESCs+2i 
and in cells after 8 days differentiation toward neuronal lineage (NPCs, neuronal progenitors). Bar chart represents the 
amounts of rRNA gene variants  resistant to HpaII digestion (i.e. methylated at CpG -142). Measurements were performed in 
triplicates and values were calculated as described in (A). (D) Bar chart shows the abundance of +44A, +44G and +44T rRNA 
variants in ESCs+serum line. (E) rRNA variant methylation in ESCs+serum and NPCs derived upon 8 days of differentiation 
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6.4 Expression of rRNA gene variants 
DNA methylation is an epigenetic mark associated with gene silencing and repressed 
transcription (see chapter 3.2). Cytosine methylation can change the DNA structure and 
alter the binding of DNA binding proteins, which may modulate transcription. Some DNA 
binding proteins, as for example certain transcription factors are only able to interact with 
their target sequence if not methylated. Hence CpG methylation directly abolishes their 
interaction with the DNA and leads to lower transcription levels (Clark, Harrison et al. 
1997). rRNA genes represent an important example of how DNA methylation affects gene 
transcription. Methylation of the rRNA gene promoter affects chromatin structures and 
impairs the association of the RNA Polymerase I (Pol I) transcription factor upstream bing 
factor (UBF), thereby preventing assembly of pre-initiation complex and repressing 
transcription (Santoro and Grummt 2001).  
The data described so far have shown that CpG methylation of rRNA genes in ESCs+2i 
and ESCs+serum is very low and rRNA genes acquired methylation only upon 
differentiation (Figures 14,15). Moreover, the results also showed that methylation at 
rRNA genes is not randomly distributed but +44T and +44G-rRNA variants are more 
prone than +44A-rRNA variants to acquire CpG methylation. To understand whether the 
acquisition of DNA methylation depends on the transcription state and whether increased 
CpG methylation during differentiation affects transcription we measured rRNA expression 
levels in ESCs and NPCs.  
To measure the rRNA gene transcription, we purified total RNA from ESCs+2i and 
NPCs/2i. After reverse transcription (RT) with random examer primers, the cDNA was 
used for qPCR in order to quantify the expression levels of rRNA genes. The 45S pre-
rRNA is the transcript originating from rRNA genes (Figure 16A). The half-life of 45S pre-
rRNA is short since upon transcription this rRNA is immediately processed to generate 
18S and 28S rRNA, which in turn have ca. 2-days half-life (Moss, Langlois et al. 2007)). 
Therefore, the quantification of rRNA transcription is generally analyzed through 
measurements of 45S pre-rRNA levels obtained by the amplification of sequences 
encompassing the 1st processing site, located between +500 and +700 relative to 
transcription start site (Figure 16A) (Santoro 2005). Since the aim of this study was also 
to measure transcription of +44 rRNA variants by quantitative PCR, we had no alternative 
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than to measure rRNA transcripts encompassing the 5'-rRNA sequences (from +1 to +65) 
(Figure 16A). Nevertheless, it is very unluckily that these transcripts have a long-half life 
since they are not part of the ribosomes. To ensure that quantifications of rRNA 
sequences at the 5' rRNA regions correspond to the values obtained by quantifying the 
sequence encompassing the 1st rRNA processing site (45S-pre-rRNA), we measured 
rRNA transcripts in ESCs and NPCs and compared the values obtained with the 
amplification using the two respective primer pairs (Figure 16B,C). We did not observe 
remarkable difference between 45S-pre-rRNA and +1/+66 rRNA levels in ESCs and 
NPCs, suggesting that values obtained with both primer pairs well represent rRNA 
transcription measurements.  
The data described in the previous sections determined that rRNA genes in ESCs+2i 
contain low methylation (2.72%), whereas upon differentiation 20.2% of the rRNA genes 
acquire de novo methylation (Figure 14 and 15). Although it would be expected a 
decrease of rRNA transcription in NPCs, in this experiment I did not observe any change. 
The reason of this result is not clear since previous data have shown downregulation of 
rRNA transcription upon differentiation (Savic, Bar et al. 2014). 
 
  
Figure 16 Measurements of rRNA transcription in ESCs and NPCs. (A) Schema represents the 5' region of one rRNA gene 
repeat, the 45S pre-rRNA (blue line) and the 1st rRNA processing site (blue star). Primer and their position are represented as 
black arrows. The blue arrow shows the transcription start site. (B) rRNA gene expression measured with the primer pair (+550 
/ +745) amplifying the region encompassing the 1st rRNA processing site, which represent the 45S pre-rRNA. Values are 
normalized to rps12 mRNA levels. (C) rRNA gene expression measured with the primer pair (+1/ +66 ) amplifying 5'-region of 
rRNA transcript. Values are normalized to rps12 mRNA levels 
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According to the data shown in Figure 15B, in ESCs+2i the +44G-rRNA variant is the 
most frequently methylated gene variant (5.7%), whereas +44A and +44T-rRNA variants 
are mostly unmethylated. Upon differentiation, de novo CpG methylation occurs 
particularly at the +44G-rRNA- and +44T-rRNA variants (16.3% and 17.9% respectively), 
while only 9.1% of the rRNA-A gene variant acquires methylation. Since CpG methylation 
during differentiation is not equally distributed amongst the different rRNA gene variants, 
we reasoned to measure expression levels of rRNA subclasses containing a SNP at +44 
to determine whether CpG methylation in differentiated cells affects their transcription. 
Analysis of +44-rRNA variants indicated that in both ESCs and NPCs transcripts 
originated from +44G-rRNA genes are about the half of +44A or +44T-rRNAs (Figure 17). 
Considering the relative amounts of +44-rRNA variants and hypothesizing that all rRNA 
genes transcribe in ESCs because of the lack of the repressive DNA methylation, +44T-
rRNA genes are the most active genes in both ESCs and NPCs (4-fold higher than +44A 
and 7-fold higher that +44G variants). Accordingly, +44G-rRNA variants are the less 
transcribed genes (ca. 50% less active than +44A-rRNA variants). These results indicate 
that the degree of methylation does not correlate with transcription levels since the 
variants with higher methylation (+44G and +44T) have a similar down-regulation as the 
+44A-rRNA variants, which are less methylated upon differentiation. Moreover, they 
indicate that the genes with the highest transcription in ESCs (+44T-rRNA variants) 
undergo preferential de novo methylation upon exit from pluripotency. Although these 
descriptive data still require further validation using different experimental settings (i.e. 
time-point analysis during differentiation), they indicate that sequence heterogeneity at 
rRNA genes might also affect the transcriptional efficiency, a working model that will be 
object of future studies in our lab. 
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6.5 CpG methylation of rRNA gene variants in NIH3T3 cells 
The results described in Figure 11 determined that the distribution of rRNA gene variants 
vary between individuals. For example, whereas in ESCs+2i +44A-rRNA gene variant is 
the most abundant variant (49.5% of all rRNA genes), in NIH3T3 cells it is the least 
frequent variant (21.9%). In contrast, +44T-rRNA variant is the most abundant in NIH3T3 
(40%), whereas the ESCs+serum line lacks this variant. Moreover, the results in Figure 
15 revealed that in ESCs+2i and ESCs+serum defined classes of rRNA genes (+44G and 
and +44T-rRNA variants) are more prone to acquire DNA methylation upon ESCs 
differentiation than the +44A-rRNA genes. Finally, whereas both analyzed ESCs line lack 
Figure 17 Analysis of the rRNA gene variant expression in ESCs and NPCs. (A) Schema represents the 5' region of one 
rRNA gene repeat, the 45S pre-rRNA (blue line) and the 1st rRNA processing site (blue star). +44-SNP primers used for RT-
qPCR are represented as arrows (orange, +44A; blue, +44G; green, +44T). (B) Relative transcription of +44-rRNA variants. 
Data were normalize to the amounts of the +44A-rRNA transcript in ESCs. (C) Transcription efficiency of +44-rRNA variants. 
Values were calculated by normalizing the amounts of transcripts to the number of rRNA variant. The formula shows the 
example how +44A-rRNA transcription efficiency has been calculated.  
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a polymorphism at -104, rRNA genes in NIH3T3 cells (also in mouse C57BL/6 genome) 
contain either A or C at -104 (Figure 11B).  
To determine whether also in NIH3T3 cells certain rRNA gene subclasses are more likely 
to acquire CpG methylation, we measured the resistance to HpaII digestion at the 
promoter of the different rRNA variants. We initially quantified the amount of CpG 
methylation at total rRNA genes in NIH3T3 cells and found that 32.6% of rRNA genes are 
methylated, which is very close to previous results showing ca. 40% rRNA gene 
methylation in NIH3T3 cells (Santoro and Grummt 2001) (Figure 18B).  
 
To determine whether a certain subclass of rRNA genes shows higher levels of CpG 
methylation respect to others, we have first measured methylation levels of the different 
rRNA gene variants containing the SNP at position +44. Our results described in section 
6.3 (Figure 15) have shown that upon differentiation of ESCs+2i and ESCs+serum the 
+44A-rRNA gene variants acquire less CpG methylation compared to +44G and +44T 
variants. Interestingly, +44A rRNA variants are also less methylated (2% off all rRNA 
genes) than +44G-rRNA genes (8.3%) and +44T-rRNA genes (18.7%). The fact that a 
large fraction of methylated sequences are +44T-rRNA genes in NIH3T3 cells is 
consistent with our data showing that upon differentiation of ESCs+2i (which contain 
+44T-rRNA genes) this variant has the highest level of methylation (17.9%) (Figure 18D). 
These data further support a model in which certain subclasses of rRNA genes is more 
prone to acquire DNA methylation than others.  
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As described above, in contrast to ESCs+2i and ESCs+serum lines, rRNA genes in 
NIH3T3 contain a further SNP at -104 (A or C). Remarkably, recent data have shown the -
104A-rRNA variant undergoes methylation in the offspring of mice subject to protein-
restricted diet during pregnancy and that this specific methylation correlates negatively 
with weaning weight (Holland, Lowe et al. 2016).  
To measure CpG methylation, we had to adapt our strategy since the forward -104C and 
the reverse -104A primers did not pass our quality control, being unable to amplify the 
corresponding variants in a specific manner (Figure 10). These primers would have 
allowed to use a strategy similar to the one used for +44 variants. This is particularly 
evident for the measurement of methylation at -142 CpG in the -104A variant, which could 
Figure 18 CpG methylation levels of rRNA genes in NIH3T3 cells. (A) Shows the strategy used to measure CpG methylation of 
total rRNA genes in NIH3T3 cells. (B) Shows values of CpG methylation at rRNa genes. (C) Quantification of +44-rRNA variants in 
NIH3T3 cells. Upper panel shows the strategy used to measure the specific variants. Measurements were normalized to total 
amount of rRNA genes calculated as the sum of the amplified variants. (D) Methylation of +44A-rRNA gene variants in NIH3T3 cells. 
Upper panel shows the strategy used to measure methylation. Measurements were normalized to total amount of rRNA genes 
calculated as shown in panel A 
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have been measured through amplification of HpaII digested DNA with the forward -165  
(-165 for) and the reverse -104A primers. Therefore, the lack of specificity of the reverse    
-104A primers does not allow a direct measurement of methylation of -104A-rRNA variant. 
On the other hand, the reverse -104C (-104C rev), which passed all the criteria for the 
specific SNP amplification, could be used in combination with the -165 for primer to 
amplify HpaII resistant (i.e. methylated at -142 CpG) -104C-variants. However, since the 
forward -104C primer lacked specificity, the total amount of -104C variants from HpaII 
digested DNA could not be measured in the same sample. We therefore decided to 
measure methylation of -104C-rRNA gene variants by comparing the amounts of DNA 
amplified with -165 for and -104C rev primer pair from NIH3T3 genomic DNA digested 
and not digested with HpaII (Figure 19A). Accordingly, values obtained from HpaII 
digested DNA will refer to methylated rRNA sequences whereas values obtained from 
untreated DNA represent the total amounts of rRNA genes. To ensure that the amount of 
genomic DNA is equal in both samples (with and without HpaII), I included an additional 
control to normalize the total amount of rRNA genes through the  amplification of rRNA 
sequences not containing a HpaII (Used primer pair: +1 forward and +111 reverse). 
Finally, we reasoned that the amounts of methylated -104A-rRNA variants could be 
obtained by subtracting the amounts of methylated -104C-variant from the total amount of 
methylated rRNA genes (Figure 19A). 
The results shown in Figure 19B indicate that in NIH3T3 cells the -104C-rRNA variant is 
more abundant (65.4%) than the -104A-rRNA genes (34.6%), which is in agreement with 
the measurements described in Figure 11. Methylation analyses showed that the 
amounts of methylated -104C-variants are very similar to the total amounts of methylated 
rRNA genes, indicating that -104A variant is not methylated (Figure 19C). These results 
are consistent with our analysis of +44-rRNA gene variants, showing that methylation at 
rRNA genes is not randomly distributed and further support a model in which certain 
subclasses of rRNA genes is refractory to CpG methylation. 
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Figure 19 Analysis of methylation of -104-rRNA variants in NIH3T3 cells (A) Experimental strategy to quantify methylation levels 
of -104C-rRNA variants. HpaII digested and mock control genomic DNA from NIH3T3 cells were amplified with the indicated primers. 
The values obtained by amplification of mock control represent the total amount of -104C-rRNA variants. The values from HpaII 
digested DNA represent the methylated -104-genes. (B) Quantification of -104-rRNA variants in NIH3T3 cells. Upper panel shows the 
strategy used to measure the specific variants. Measurements were normalized to total amount of rRNA genes calculated as the sum 
of the amplified variants. (C) Relative methylation levels of -104-rRNA gene variants. Values for methylated -104C-variants were 
obtained as described in A. The upper panel describes how the levels of methylated -104A-rRNA variants were calculated. 
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7 Discussion 
An important concept that is emerging in modern biology is the cellular heterogeneity. 
This is particularly evident in cancer biology, since heterogeneity poses practical 
challenges for building accurate clinical models–particularly ones based on population-
averaged measurements–to guide diagnosis and treatment of the disease ((Campbell and 
Polyak 2007), (Altschuler and Wu 2010)) 
In contrast to cancer cells, which accumulate genetic mutations during disease 
progression, healthy cells from an individual organism are considered to contain the same 
genome and hence do not display genetic heterogeneity. However, healthy cells from the 
same individual organism can have in their genome a certain degree of sequence 
variations, which can be found between paternal and maternal alleles and in particular at 
repetitive sequences such as satellite DNA, transposable elements and rRNA genes. 
Some of these sequence are very abundant such as major satellite repeats, which are 
represented about 10,000 times in every chromosome and make up ~10% of the mouse 
genome (Garagna, Zuccotti et al. 2002) or interspersed repeats (LINE, SINE, LTRs and 
ERV elements), which comprise ∼43% of the mouse genome (Bulut-Karslioglu, De La 
Rosa-Velazquez et al. 2014). Some of the biggest technical challenges that are 
associated with next-generation sequencing projects are caused by repetitive DNA. From 
a computational perspective, repeats create ambiguities in alignment and in genome 
assembly, which, in turn, can produce errors when interpreting results (Treangen and 
Salzberg 2011). The repetitive nature of rRNA genes is not an exception. So far, only one 
mouse and one human rRNA repeat has been sequenced (Third Party Annotation 
accession numbers BK000964 and U13369), and these are generally considered to be 
the sequences of all rRNA genes (Santoro, Schmitz et al. 2010). However, the fact that all 
rRNA repeats do not share the same sequence was already evident in early studies 
showing heterogeneous patterns of restriction rRNA fragments in the non-transcribed 
spacer DNA among individuals such as BALB/c, C57BL and Mus poschiavinus strains 
and human leukemic blood cells (Arnheim and Southern 1977). Heterogeneity in rRNA 
sequences was also found in the same individuals (Cory and Adams 1977) (Erickson and 
Schmickel 1985), indicating that one genome can contain several rRNA gene subclasses 
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(rRNA variants). However, whether sequence variation in rRNA genes affects gene 
regulation remains yet elusive.  
The aim of this work was to create tools to quantify and determine whether rRNA genes 
variants differ in their regulation. We made use of single nucleotide polymorphisms that 
recent works from our and other laboratories have identified at the mouse rRNA promoter 
(-104) and downstream the transcription start site (+44) (Guetg, Lienemann et al. 2010) 
(Holland, Lowe et al. 2016). We established SNP-qPCR method that allows specific 
detection of rRNA gene variants and their quantification. The analysis of two mouse E14 
ESC lines, mouse embryonic fibroblast cells (NIH3T3) and mouse C57BL/6-tissue 
revealed not only a distinct distribution of rRNA variants among individuals but also that 
not all the variants can be present in the same genome (-104A SNP only in C57BL/6 and 
NIH3T3 cells, lack of +44T in ESCs+serum). These results clearly suggest that the 
combination of -104 and +44 SNPs, which are the only SNPs existing at rRNA gene 
promoter, can be indicative of the presence of several rRNA subclasses. For example, the 
existence of SNPs at -104 (A or C) and +44 (A or T or G) in C57BL/6-tissue and NIH3T3 
cells can give rise to six rRNA gene variants (-104C/+44A, -104C/+44T, -104C/+44G, -
104A/+44A, -104A/+44T, -104A/+44G) whereas the ESCs+2i line can have only three 
variants (-104C/+44A, -104C/+44T, -104C/+44G) and ESCs+serum only two (-104C/+44A, 
-104C/+44G). Future analyses will be aimed to quantify all these subclasses and 
determine further variations in regulatory sequences located upstream the main promoter 
such as the enhancer repeat region, which is also known to differ in length between rRNA 
copies of the same cells (Santoro, Schmitz et al. 2010). Finally, according to our protocol, 
the analyses of SNPs at rRNA genes can be easily adapted to human cells. This is of 
particular importance since rRNA transcription is often altered in cancer ((Nguyen le, 
Raval et al. 2015). Determine whether alterations of rRNA gene transcription in cancer 
correlates with changes in rRNA copy number and genes subclasses will be an aim of our 
future investigation. 
The lack of +44T-variants in one of the ESC line (ESCs+serum) was a surprising result 
since both lines derive from mus musculus strain 129/Ola and therefore should have the 
same genetic background. However, they have been generated in different labs and it can 
be plausible that ESCs+serum line has lost these sequences during culture. The fact that 
mouse rRNA genes are clustered together on different 5 chromosomes makes the lack of 
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+44T-variants an interesting result that is currently under investigation. Indeed, the lack of 
+44T-sequences can instruct us about the distribution and chromosomal location of rRNA 
genes, which is so far completely ignored. Indeed, we reason that the lack of +44-rRNA 
genes in ESCs+serum line can be easily explained if we consider that all +44T-sequences 
have to cluster together on the same chromosome and that the ESCs+serum line during 
culture has undergone genomic instability by losing either the chromosome containing the 
+44T-copies or the entire rRNA locus at one chromosome.  We are currently testing this 
hypothesis by analyzing and comparing the karyotype and the distribution of rRNA genes 
between the two ESC lines. If this turns to be true (i.e. +44T-variants are all located on 
one chromosome), this will represent an unprecedented opportunity to track rRNA gene 
variants in cells and define their spatial localization and organization in the nucleoli. 
 
The establishment of a quantitative method to measure rRNA gene variants allowed 
exploring how rRNA gene variants are regulated during development. Previous studies 
have shown that upon ESC differentiation a fraction of rRNA genes is epigenetically 
silenced through epigenetic modifications mediated by TIP5 (Savic, Bar et al. 2014) 
(Leone, Bar et al. 2017). An important epigenetic modification at rRNA genes is 
methylation of DNA, which in mammals occurs at cytosine within the CpG sequences. A 
question arising from these studies is whether epigenetic silencing at rRNA genes upon 
exit from pluripotency state is a random event (i.e. any rRNA gene can be epigenetically 
silenced) or whether a defined set of rRNA genes is specifically CpG methylated and 
transcriptionally repressed. Our analyses revealed that +44A-rRNA genes are less prone 
to be methylated whereas +44G and +44T-variants are the major targets for de novo 
methylation. These data strongly indicate that upon ESC differentiation methylation at 
rRNA genes is not randomly distributed but some rRNA gene variants are more prone to 
acquire CpG methylation. Similar results were obtained in NIH3T3 cells where the +44A 
variants are considerably hypomethylated compared to the other genes, a result that is 
consistent with previous studies (Guetg, Lienemann et al. 2010).  Strikingly, -104A-rRNA 
gene variants in NIH3T3 cells lack completely CpG methylation, supporting a model in 
which deposition of repressive epigenetic marks is influenced by rRNA sequences. 
 
    Epigenetic analysis of ribosomal RNA sequence heterogeneity in embryonic stem cells 
 
 
Page 71      
 
 
Previous results have shown that rRNA genes are maintained in a hypomethylated state 
in ground state pluripotent ESCs (ESCs+2i). The results of this work are consistent with 
these data and further support a functional link between hypomethylated rRNA genes and 
the pluripotency state. The analysis of DNA methylation upon ESC differentiation revealed 
that rRNA genes maintain a hypomethylated state in both ground-state pluripotent cells 
(ESCs+2i) and ESCs primed toward differentiation (ESCs+serum). These two ESC states 
can be distinguished by the expression of de novo DNMT3A and DNMT3B (low in 
ESCs+2i, high in ESCs+serum), which result in distinct CpG methylation content (low in 
ESCs+2i, high in ESCs+serum) ((Leitch, McEwen et al. 2013),(Ficz, Hore et al. 2013)). 
Thus, the results shown in this work indicated that also in the case of ESCs with high DNA 
methylation potential (ESCs+serum), rRNA genes remain refractory to DNA methylation. 
Recent results have proposed that controlling the epigenetic silencing of rRNA genes is 
required for the maintenance of pluripotency and the entrance into differentiation 
pathways (Savic, Bar et al. 2014) (Leone, Bar et al. 2017).  One of these studies 
suggested that an active state of rRNA genes is beneficial for the maintenance of 
pluripotency since tethering epigenetic silencing at rRNA genes in ESCs+2i primed cells 
for differentiation through the acquisition of features of differentiated cells such 
heterochromatic structures, transcription of differentiation genes and impaired formation of 
teratoma (Savic, Bar et al. 2014). Moreover, a recent work from our group revealed that 
abrogation of epigenetic silencing at rRNA genes impairs ESC differentiation, suggesting 
that silent rRNA genes are required to let pluripotency cells to exit from the pluripotent 
state (Leone, Bar et al. 2017). Although how the epigenetic state of rRNA genes is 
functionally linked with the pluripotency state of ESCs remains yet to be elucidated, it is 
clear that transcription of rRNA and ribosome biogenesis are not the unique players of this 
process. Indeed, one effect observed upon abrogation of epigenetic silencing of rRNA 
genes during ESC differentiation is cell death (Savic, Bar et al. 2014) (Leone, Bar et al. 
2017).  It is unlikely that cells with high rRNA levels undergo cell death since ribosome 
biogenesis is well known to be positively correlated with cell viability and proliferation 
(Moss 2004). Moreover, the amount of rRNA transcripts does not always depend on the 
number of active genes since cells with low number of rRNA gene copies can 
compensate by upregulating elongation rate (Moss, Langlois et al. 2007)). This can also 
be observed in the transcriptional analysis of this work, which showed that NPCs that 
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contains about 30% of silent rRNA genes still transcribe at levels similar to ESCs, which 
have all rRNA genes in an active state. Evidences have started to indicate that silent 
rRNA genes can contribute to genome organization since induction of rRNA gene 
silencing in ESCs resulted in a drastic change of genome architecture with the 
appearance of highly condensed heterochromatic blocks outside the nucleolus, a global 
increase in the repressive histone mark H3K9me2, maturation of heterochromatin as 
major and minor satellites and their transcriptional repression as found in differentiated 
cells (Savic, Bar et al. 2014).   Although the mechanism by which the nucleolus acts in the 
global restructuring of genome architecture is yet unknown, what is clear is that it also 
depends on the chromatin state of rRNA genes since the gain of heterochromatin at rRNA 
genes induces the rest of the genome to remodel into highly condensed structures 
(Leone, Bar et al. 2017). The establishment of a quantitative method to measure rRNA 
gene variants will help to better understand how the chromatin architecture at defined 
rRNA genes contribute into this process.  
 
An unexpected result obtained in this study is that the +44T-rRNA gene is the variant with 
the highest transcription activity in ESCs and is also more prone to acquire de novo 
methylation during ESC differentiation. Indeed, +44-rRNA genes are ca. 3.5 fold less 
abundant than +44A-variants, yet the amounts of +44T-transcripts in ESCs are very 
similar to +44A-rRNA levels. Although the interpretation of these results is based on the 
assumption that all rRNA genes in ESCs transcribe because they all lack CpG 
methylation, the results shown in this study are worth of further investigations aimed to 
understand how specific rRNA genes are targeted for epigenetic silencing upon 
differentiation. The development of the SNP-qPCR will be an important tool for future 
chromatin immunoprecipitation (ChIP) analyses to determine the occupancy of the Pol I 
transcription machinery, the repressor TIP5 as well as histone modifications at rRNA 
variants before and after differentiation, offering important insights on the composition of 
chromatin structure. 
 
Taken together, the results of this study represent an initial step toward the deciphering of 
how genetic variation influences transcription and epigenetic regulation at rRNA genes, 
which might be useful for the understanding of complex diseases like cancer.   
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